{
	"target_details": {
		"ensembl_id": "ENSG00000282608",
		"hgnc_id": "HGNC:268",
		"uniprot_id": "P0DMS8"
	},
	"about_target": {
		"introduction": {
			"Accession": "P0DMS8",
			"Protein": "Adenosine receptor A3",
			"Gene": "ADORA3",
			"Status": "UniProtKB reviewed (Swiss-Prot)",
			"Organism": "Homo sapiens",
			"Protein Existence": "1: Evidence at protein level",
			"Annotation Score": 5
		},
		"summary_and_characteristics": {
			"Target ID": "ENSG00000282608",
			"Function Descriptions": "[Isoform 2]: Receptor for adenosine. The activity of this receptor is mediated by G proteins which inhibits adenylyl cyclase (PubMed:8234299). .",
			"Synonyms": {
				"UniProt Synonyms": ["Adenosine receptor A3", "ADORA3"]
			}
		},
		"taxonomy": {
			"Taxonomic Identifier": 9606,
			"Organism": "Homo sapiens (Human)",
			"Taxonomic Lineage": [
				"Eukaryota",
				"Metazoa",
				"Chordata",
				"Craniata",
				"Vertebrata",
				"Euteleostomi",
				"Mammalia",
				"Eutheria",
				"Euarchontoglires",
				"Primates",
				"Haplorrhini",
				"Catarrhini",
				"Hominidae",
				"Homo"
			]
		}
	},
	"target_biology": {
		"ontology": [
			{
				"GO ID": "GO:0030336",
				"Name": "negative regulation of cell migration",
				"Aspect": "Biological Process",
				"Evidence": "IMP",
				"Gene Product": "P0DMS8",
				"Source": "PMID:27886186",
				"Link": "https://amigo.geneontology.org/amigo/term/GO:0030336"
			},
			{
				"GO ID": "GO:0007165",
				"Name": "signal transduction",
				"Aspect": "Biological Process",
				"Evidence": "TAS",
				"Gene Product": "P0DMS8",
				"Source": "PMID:9380026",
				"Link": "https://amigo.geneontology.org/amigo/term/GO:0007165"
			},
			{
				"GO ID": "GO:0008016",
				"Name": "regulation of heart contraction",
				"Aspect": "Biological Process",
				"Evidence": "TAS",
				"Gene Product": "P0DMS8",
				"Source": "PMID:9837869",
				"Link": "https://amigo.geneontology.org/amigo/term/GO:0008016"
			},
			{
				"GO ID": "GO:0032088",
				"Name": "negative regulation of NF-kappaB transcription factor activity",
				"Aspect": "Biological Process",
				"Evidence": "IMP",
				"Gene Product": "P0DMS8",
				"Source": "PMID:27886186",
				"Link": "https://amigo.geneontology.org/amigo/term/GO:0032088"
			},
			{
				"GO ID": "GO:0005886",
				"Name": "plasma membrane",
				"Aspect": "Cellular Component",
				"Evidence": "IBA",
				"Gene Product": "P0DMS8",
				"Source": "GO_REF:0000033",
				"Link": "https://amigo.geneontology.org/amigo/term/GO:0005886"
			},
			{
				"GO ID": "GO:0001609",
				"Name": "G protein-coupled adenosine receptor activity",
				"Aspect": "Molecular Function",
				"Evidence": "IBA",
				"Gene Product": "P0DMS8",
				"Source": "GO_REF:0000033",
				"Link": "https://amigo.geneontology.org/amigo/term/GO:0001609"
			},
			{
				"GO ID": "GO:0005886",
				"Name": "plasma membrane",
				"Aspect": "Cellular Component",
				"Evidence": "TAS",
				"Gene Product": "P0DMS8",
				"Source": "Reactome:R-HSA-380073",
				"Link": "https://amigo.geneontology.org/amigo/term/GO:0005886"
			},
			{
				"GO ID": "GO:0042734",
				"Name": "presynaptic membrane",
				"Aspect": "Cellular Component",
				"Evidence": "IEA",
				"Gene Product": "P0DMS8",
				"Source": "GO_REF:0000107",
				"Link": "https://amigo.geneontology.org/amigo/term/GO:0042734"
			},
			{
				"GO ID": "GO:0014061",
				"Name": "regulation of norepinephrine secretion",
				"Aspect": "Biological Process",
				"Evidence": "IEA",
				"Gene Product": "P0DMS8",
				"Source": "GO_REF:0000107",
				"Link": "https://amigo.geneontology.org/amigo/term/GO:0014061"
			},
			{
				"GO ID": "GO:0099171",
				"Name": "presynaptic modulation of chemical synaptic transmission",
				"Aspect": "Biological Process",
				"Evidence": "IEA",
				"Gene Product": "P0DMS8",
				"Source": "GO_REF:0000107",
				"Link": "https://amigo.geneontology.org/amigo/term/GO:0099171"
			},
			{
				"GO ID": "GO:0005886",
				"Name": "plasma membrane",
				"Aspect": "Cellular Component",
				"Evidence": "TAS",
				"Gene Product": "P0DMS8",
				"Source": "Reactome:R-HSA-749456",
				"Link": "https://amigo.geneontology.org/amigo/term/GO:0005886"
			},
			{
				"GO ID": "GO:0045202",
				"Name": "synapse",
				"Aspect": "Cellular Component",
				"Evidence": "IBA",
				"Gene Product": "P0DMS8",
				"Source": "GO_REF:0000033",
				"Link": "https://amigo.geneontology.org/amigo/term/GO:0045202"
			},
			{
				"GO ID": "GO:0098685",
				"Name": "Schaffer collateral - CA1 synapse",
				"Aspect": "Cellular Component",
				"Evidence": "IEA",
				"Gene Product": "P0DMS8",
				"Source": "GO_REF:0000107",
				"Link": "https://amigo.geneontology.org/amigo/term/GO:0098685"
			},
			{
				"GO ID": "GO:0030425",
				"Name": "dendrite",
				"Aspect": "Cellular Component",
				"Evidence": "IBA",
				"Gene Product": "P0DMS8",
				"Source": "GO_REF:0000033",
				"Link": "https://amigo.geneontology.org/amigo/term/GO:0030425"
			},
			{
				"GO ID": "GO:0005886",
				"Name": "plasma membrane",
				"Aspect": "Cellular Component",
				"Evidence": "TAS",
				"Gene Product": "P0DMS8",
				"Source": "Reactome:R-HSA-749454",
				"Link": "https://amigo.geneontology.org/amigo/term/GO:0005886"
			},
			{
				"GO ID": "GO:0001973",
				"Name": "G protein-coupled adenosine receptor signaling pathway",
				"Aspect": "Biological Process",
				"Evidence": "IBA",
				"Gene Product": "P0DMS8",
				"Source": "GO_REF:0000033",
				"Link": "https://amigo.geneontology.org/amigo/term/GO:0001973"
			},
			{
				"GO ID": "GO:0006954",
				"Name": "inflammatory response",
				"Aspect": "Biological Process",
				"Evidence": "TAS",
				"Gene Product": "P0DMS8",
				"Source": "PMID:9164961",
				"Link": "https://amigo.geneontology.org/amigo/term/GO:0006954"
			},
			{
				"GO ID": "GO:0007165",
				"Name": "signal transduction",
				"Aspect": "Biological Process",
				"Evidence": "TAS",
				"Gene Product": "P0DMS8",
				"Source": "PMID:8399349",
				"Link": "https://amigo.geneontology.org/amigo/term/GO:0007165"
			},
			{
				"GO ID": "GO:0008285",
				"Name": "negative regulation of cell population proliferation",
				"Aspect": "Biological Process",
				"Evidence": "IMP",
				"Gene Product": "P0DMS8",
				"Source": "PMID:27886186",
				"Link": "https://amigo.geneontology.org/amigo/term/GO:0008285"
			},
			{
				"GO ID": "GO:0005886",
				"Name": "plasma membrane",
				"Aspect": "Cellular Component",
				"Evidence": "TAS",
				"Gene Product": "P0DMS8",
				"Source": "Reactome:R-HSA-418904",
				"Link": "https://amigo.geneontology.org/amigo/term/GO:0005886"
			},
			{
				"GO ID": "GO:0007190",
				"Name": "activation of adenylate cyclase activity",
				"Aspect": "Biological Process",
				"Evidence": "TAS",
				"Gene Product": "P0DMS8",
				"Source": "PMID:9380026",
				"Link": "https://amigo.geneontology.org/amigo/term/GO:0007190"
			},
			{
				"GO ID": "GO:0009611",
				"Name": "response to wounding",
				"Aspect": "Biological Process",
				"Evidence": "TAS",
				"Gene Product": "P0DMS8",
				"Source": "PMID:9837869",
				"Link": "https://amigo.geneontology.org/amigo/term/GO:0009611"
			}
		],
		"protein_expressions": {
			"data": [
				{
					"immune organ": [
						{
							"Tissue": "macrophage",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "memory B cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "regulatory T cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "plasma cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "CD34-negative, CD41-positive, CD42-positive megakaryocyte cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "mature neutrophil",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "granulocyte monocyte progenitor cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "CD4-positive, alpha-beta T cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "CD14-positive, CD16-negative classical monocyte",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "effector memory CD4-positive, alpha-beta T cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "central memory CD8-positive, alpha-beta T cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "segmented neutrophil of bone marrow",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "inflammatory macrophage",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "leukocyte",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "CD4-positive, alpha-beta thymocyte",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "spleen",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "conventional dendritic cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "alternatively activated macrophage",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "mature eosinophil",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "EBV-transformed lymphocyte",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "CD38-negative naive B cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "CD8-positive, alpha-beta T cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "neutrophilic metamyelocyte",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "class switched memory B cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "CD8-positive, alpha-beta thymocyte",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "cytotoxic CD56-dim natural killer cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "CD3-positive, CD4-positive, CD8-positive, double positive thymocyte",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "effector memory CD8-positive, alpha-beta T cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "lymph node",
							"RNA Z-Score": 2,
							"Protein Level": 0
						},
						{
							"Tissue": "central memory CD4-positive, alpha-beta T cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						}
					]
				},
				{
					"blood": [
						{
							"Tissue": "macrophage",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "memory B cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "regulatory T cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "endothelial cell of umbilical vein (resting)",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "plasma cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "CD34-negative, CD41-positive, CD42-positive megakaryocyte cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "mature neutrophil",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "granulocyte monocyte progenitor cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "CD4-positive, alpha-beta T cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "CD14-positive, CD16-negative classical monocyte",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "endothelial cell of umbilical vein (proliferating)",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "hematopoietic stem cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "common myeloid progenitor",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "effector memory CD4-positive, alpha-beta T cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "central memory CD8-positive, alpha-beta T cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "inflammatory macrophage",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "hematopoietic multipotent progenitor cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "conventional dendritic cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "alternatively activated macrophage",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "mature eosinophil",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "CD38-negative naive B cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "erythroblast",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "common lymphoid progenitor",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "CD8-positive, alpha-beta T cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "neutrophilic metamyelocyte",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "class switched memory B cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "cytotoxic CD56-dim natural killer cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "megakaryocyte-erythroid progenitor cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "blood",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "effector memory CD8-positive, alpha-beta T cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "central memory CD4-positive, alpha-beta T cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						}
					]
				},
				{
					"brain": [
						{
							"Tissue": "putamen",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "cerebral cortex",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "amygdala",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "brain",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "cerebellum",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "caudate nucleus",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "Brodmann (1909) area 24",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "frontal lobe",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "temporal lobe",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "prefrontal cortex",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "Brodmann (1909) area 9",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "hippocampus proper",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "hypothalamus",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "nucleus accumbens",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "cerebellar hemisphere",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "pituitary gland",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "substantia nigra",
							"RNA Z-Score": 0,
							"Protein Level": 0
						}
					]
				},
				{
					"reproductive organ": [
						{
							"Tissue": "uterus",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "endometrium",
							"RNA Z-Score": 2,
							"Protein Level": 0
						},
						{
							"Tissue": "testis",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "ectocervix",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "vagina",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "ovary",
							"RNA Z-Score": 0,
							"Protein Level": 0
						}
					]
				},
				{
					"reproductive structure": [
						{
							"Tissue": "uterus",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "endometrium",
							"RNA Z-Score": 2,
							"Protein Level": 0
						},
						{
							"Tissue": "testis",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "ectocervix",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "vagina",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "endocervix",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "prostate gland",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "fallopian tube",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "placenta",
							"RNA Z-Score": 2,
							"Protein Level": 0
						}
					]
				},
				{
					"connective tissue": [
						{
							"Tissue": "subcutaneous adipose tissue",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "adipose tissue",
							"RNA Z-Score": 2,
							"Protein Level": 0
						},
						{
							"Tissue": "transformed skin fibroblast",
							"RNA Z-Score": 0,
							"Protein Level": 0
						}
					]
				},
				{
					"stomach": [
						{
							"Tissue": "stomach",
							"RNA Z-Score": 0,
							"Protein Level": 0
						}
					]
				},
				{
					"endocrine gland": [
						{
							"Tissue": "adrenal gland",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "thyroid gland",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "CD4-positive, alpha-beta thymocyte",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "CD8-positive, alpha-beta thymocyte",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "liver",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "pituitary gland",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "CD3-positive, CD4-positive, CD8-positive, double positive thymocyte",
							"RNA Z-Score": 0,
							"Protein Level": 0
						}
					]
				},
				{
					"bladder organ": [
						{
							"Tissue": "gall bladder",
							"RNA Z-Score": 3,
							"Protein Level": 0
						},
						{
							"Tissue": "urinary bladder",
							"RNA Z-Score": 0,
							"Protein Level": 0
						}
					]
				},
				{
					"musculature": [
						{
							"Tissue": "skeletal muscle tissue",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "smooth muscle tissue",
							"RNA Z-Score": 2,
							"Protein Level": 0
						},
						{
							"Tissue": "esophagus muscularis mucosa",
							"RNA Z-Score": 0,
							"Protein Level": 0
						}
					]
				},
				{
					"intestine": [
						{
							"Tissue": "vermiform appendix",
							"RNA Z-Score": 3,
							"Protein Level": 0
						},
						{
							"Tissue": "colon",
							"RNA Z-Score": 3,
							"Protein Level": 0
						},
						{
							"Tissue": "small intestine",
							"RNA Z-Score": 3,
							"Protein Level": 0
						},
						{
							"Tissue": "duodenum",
							"RNA Z-Score": 2,
							"Protein Level": 0
						},
						{
							"Tissue": "small intestine Peyer's patch",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "sigmoid colon",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "transverse colon",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "rectum",
							"RNA Z-Score": 3,
							"Protein Level": 0
						}
					]
				},
				{
					"colon": [
						{
							"Tissue": "vermiform appendix",
							"RNA Z-Score": 3,
							"Protein Level": 0
						},
						{
							"Tissue": "colon",
							"RNA Z-Score": 3,
							"Protein Level": 0
						},
						{
							"Tissue": "sigmoid colon",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "transverse colon",
							"RNA Z-Score": 0,
							"Protein Level": 0
						}
					]
				},
				{
					"mucosa": [
						{
							"Tissue": "endometrium",
							"RNA Z-Score": 2,
							"Protein Level": 0
						},
						{
							"Tissue": "small intestine Peyer's patch",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "esophagus mucosa",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "minor salivary gland",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "esophagus muscularis mucosa",
							"RNA Z-Score": 0,
							"Protein Level": 0
						}
					]
				},
				{
					"skeletal element": [
						{
							"Tissue": "bone marrow",
							"RNA Z-Score": 1,
							"Protein Level": 0
						},
						{
							"Tissue": "CD34-negative, CD41-positive, CD42-positive megakaryocyte cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "granulocyte monocyte progenitor cell",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "segmented neutrophil of bone marrow",
							"RNA Z-Score": 0,
							"Protein Level": 0
						}
					]
				},
				{
					"skin of body": [
						{
							"Tissue": "suprapubic skin",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "zone of skin",
							"RNA Z-Score": 1,
							"Protein Level": 0
						},
						{
							"Tissue": "lower leg skin",
							"RNA Z-Score": 0,
							"Protein Level": 0
						}
					]
				},
				{
					"heart": [
						{
							"Tissue": "coronary artery",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "atrium auricular region",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "heart left ventricle",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "heart",
							"RNA Z-Score": 1,
							"Protein Level": 0
						}
					]
				},
				{
					"vasculature": [
						{
							"Tissue": "coronary artery",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "tibial artery",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "aorta",
							"RNA Z-Score": 0,
							"Protein Level": 0
						}
					]
				},
				{
					"pharynx": [
						{
							"Tissue": "tonsil",
							"RNA Z-Score": 2,
							"Protein Level": 0
						}
					]
				},
				{
					"spinal cord": [
						{
							"Tissue": "C1 segment of cervical spinal cord",
							"RNA Z-Score": 0,
							"Protein Level": 0
						}
					]
				},
				{
					"exocrine gland": [
						{
							"Tissue": "saliva-secreting gland",
							"RNA Z-Score": 2,
							"Protein Level": 0
						},
						{
							"Tissue": "minor salivary gland",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "liver",
							"RNA Z-Score": 0,
							"Protein Level": 0
						}
					]
				},
				{
					"oral gland": [
						{
							"Tissue": "saliva-secreting gland",
							"RNA Z-Score": 2,
							"Protein Level": 0
						},
						{
							"Tissue": "minor salivary gland",
							"RNA Z-Score": 0,
							"Protein Level": 0
						}
					]
				},
				{
					"peritoneum": [
						{
							"Tissue": "greater omentum",
							"RNA Z-Score": 0,
							"Protein Level": 0
						}
					]
				},
				{
					"esophagus": [
						{
							"Tissue": "esophagus mucosa",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "esophagus",
							"RNA Z-Score": 2,
							"Protein Level": 0
						},
						{
							"Tissue": "esophagus muscularis mucosa",
							"RNA Z-Score": 0,
							"Protein Level": 0
						}
					]
				},
				{
					"spleen": [
						{
							"Tissue": "spleen",
							"RNA Z-Score": 0,
							"Protein Level": 0
						}
					]
				},
				{
					"pancreas": [
						{
							"Tissue": "pancreas",
							"RNA Z-Score": 0,
							"Protein Level": 0
						}
					]
				},
				{
					"rectum": [
						{
							"Tissue": "rectum",
							"RNA Z-Score": 3,
							"Protein Level": 0
						}
					]
				},
				{
					"esophagogastric junction": [
						{
							"Tissue": "esophagogastric junction",
							"RNA Z-Score": 0,
							"Protein Level": 0
						}
					]
				},
				{
					"kidney": [
						{
							"Tissue": "cortex of kidney",
							"RNA Z-Score": 0,
							"Protein Level": 0
						},
						{
							"Tissue": "kidney",
							"RNA Z-Score": 1,
							"Protein Level": 0
						}
					]
				},
				{
					"liver": [
						{
							"Tissue": "liver",
							"RNA Z-Score": 0,
							"Protein Level": 0
						}
					]
				},
				{
					"nerve": [
						{
							"Tissue": "tibial nerve",
							"RNA Z-Score": 0,
							"Protein Level": 0
						}
					]
				},
				{
					"lung": [
						{
							"Tissue": "lung",
							"RNA Z-Score": 0,
							"Protein Level": 0
						}
					]
				},
				{
					"breast": [
						{
							"Tissue": "breast",
							"RNA Z-Score": 0,
							"Protein Level": 0
						}
					]
				}
			]
		},
		"subcellular": [
			{
				"Type": "Topological domain",
				"Positions": "1-14",
				"Description": "Extracellular",
				"Description Link": "https://www.ebi.ac.uk/QuickGO/term/ECO:0000250",
				"Blast Link": "https://www.uniprot.org/blast?ids=P0DMS8[1-14]"
			},
			{
				"Type": "Transmembrane",
				"Positions": "15-37",
				"Description": "Helical; Name=1",
				"Description Link": "https://www.ebi.ac.uk/QuickGO/term/ECO:0000250",
				"Blast Link": "https://www.uniprot.org/blast?ids=P0DMS8[15-37]"
			},
			{
				"Type": "Topological domain",
				"Positions": "38-48",
				"Description": "Cytoplasmic",
				"Description Link": "https://www.ebi.ac.uk/QuickGO/term/ECO:0000250",
				"Blast Link": "https://www.uniprot.org/blast?ids=P0DMS8[38-48]"
			},
			{
				"Type": "Transmembrane",
				"Positions": "49-72",
				"Description": "Helical; Name=2",
				"Description Link": "https://www.ebi.ac.uk/QuickGO/term/ECO:0000250",
				"Blast Link": "https://www.uniprot.org/blast?ids=P0DMS8[49-72]"
			},
			{
				"Type": "Topological domain",
				"Positions": "73-84",
				"Description": "Extracellular",
				"Description Link": "https://www.ebi.ac.uk/QuickGO/term/ECO:0000250",
				"Blast Link": "https://www.uniprot.org/blast?ids=P0DMS8[73-84]"
			},
			{
				"Type": "Transmembrane",
				"Positions": "85-106",
				"Description": "Helical; Name=3",
				"Description Link": "https://www.ebi.ac.uk/QuickGO/term/ECO:0000250",
				"Blast Link": "https://www.uniprot.org/blast?ids=P0DMS8[85-106]"
			},
			{
				"Type": "Topological domain",
				"Positions": "107-126",
				"Description": "Cytoplasmic",
				"Description Link": "https://www.ebi.ac.uk/QuickGO/term/ECO:0000250",
				"Blast Link": "https://www.uniprot.org/blast?ids=P0DMS8[107-126]"
			},
			{
				"Type": "Transmembrane",
				"Positions": "127-148",
				"Description": "Helical; Name=4",
				"Description Link": "https://www.ebi.ac.uk/QuickGO/term/ECO:0000250",
				"Blast Link": "https://www.uniprot.org/blast?ids=P0DMS8[127-148]"
			},
			{
				"Type": "Topological domain",
				"Positions": "149-177",
				"Description": "Extracellular",
				"Description Link": "https://www.ebi.ac.uk/QuickGO/term/ECO:0000250",
				"Blast Link": "https://www.uniprot.org/blast?ids=P0DMS8[149-177]"
			},
			{
				"Type": "Transmembrane",
				"Positions": "178-198",
				"Description": "Helical; Name=5",
				"Description Link": "https://www.ebi.ac.uk/QuickGO/term/ECO:0000250",
				"Blast Link": "https://www.uniprot.org/blast?ids=P0DMS8[178-198]"
			},
			{
				"Type": "Topological domain",
				"Positions": "199-231",
				"Description": "Cytoplasmic",
				"Description Link": "https://www.ebi.ac.uk/QuickGO/term/ECO:0000250",
				"Blast Link": "https://www.uniprot.org/blast?ids=P0DMS8[199-231]"
			},
			{
				"Type": "Transmembrane",
				"Positions": "232-255",
				"Description": "Helical; Name=6",
				"Description Link": "https://www.ebi.ac.uk/QuickGO/term/ECO:0000250",
				"Blast Link": "https://www.uniprot.org/blast?ids=P0DMS8[232-255]"
			},
			{
				"Type": "Topological domain",
				"Positions": "256-261",
				"Description": "Extracellular",
				"Description Link": "https://www.ebi.ac.uk/QuickGO/term/ECO:0000250",
				"Blast Link": "https://www.uniprot.org/blast?ids=P0DMS8[256-261]"
			},
			{
				"Type": "Transmembrane",
				"Positions": "262-284",
				"Description": "Helical; Name=7",
				"Description Link": "https://www.ebi.ac.uk/QuickGO/term/ECO:0000250",
				"Blast Link": "https://www.uniprot.org/blast?ids=P0DMS8[262-284]"
			},
			{
				"Type": "Topological domain",
				"Positions": "285-318",
				"Description": "Cytoplasmic",
				"Description Link": "https://www.ebi.ac.uk/QuickGO/term/ECO:0000250",
				"Blast Link": "https://www.uniprot.org/blast?ids=P0DMS8[285-318]"
			}
		]
	},
	"competitive_landscape": {
		"known_drugs": [
			{
				"Drug": "AMINOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL1370561",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "Acute kidney injury",
				"Disease URL": "https://platform.opentargets.org/disease/HP_0001919",
				"Phase": "Phase 4",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01594489"],
				"Sponsor": "Ospedale Misericordia e Dolce"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "migraine disorder",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0005277",
				"Phase": "Phase 4",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01248468"],
				"Sponsor": "Novartis"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "Apnea",
				"Disease URL": "https://platform.opentargets.org/disease/HP_0002104",
				"Phase": "Phase 4",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT04868565"],
				"Sponsor": "Children&#x27;s Hospital of Chongqing Medical University"
			},
			{
				"Drug": "AMINOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL1370561",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "chronic kidney disease",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0003884",
				"Phase": "Phase 4",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01336140"],
				"Sponsor": "Rush University Medical Center"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "common cold",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0007214",
				"Phase": "Phase 4",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01466348"],
				"Sponsor": "GlaxoSmithKline"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "pain",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0003843",
				"Phase": "Phase 3",
				"Status": "Completed",
				"Source URLs": [
					"https://clinicaltrials.gov/study/NCT02862977",
					"https://clinicaltrials.gov/study/NCT02863575"
				],
				"Sponsor": "EMS"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "atherosclerosis",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0003914",
				"Phase": "Phase 4",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT00851175"],
				"Sponsor": "Radboud University Medical Center"
			},
			{
				"Drug": "THEOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL190",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "asthma",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0004979",
				"Phase": "Phase 4",
				"Status": "Completed",
				"Source URLs": [
					"https://clinicaltrials.gov/study/NCT02537691",
					"https://clinicaltrials.gov/study/NCT00756418",
					"https://clinicaltrials.gov/study/NCT01696214"
				],
				"Sponsor": "Hoffmann-La Roche"
			},
			{
				"Drug": "THEOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL190",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "chronic kidney disease",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0003884",
				"Phase": "Phase 4",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01336140"],
				"Sponsor": "Rush University Medical Center"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "Headache",
				"Disease URL": "https://platform.opentargets.org/disease/HP_0002315",
				"Phase": "Phase 4",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT03910088"],
				"Sponsor": "Cairo University"
			},
			{
				"Drug": "AMINOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL1370561",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "Headache",
				"Disease URL": "https://platform.opentargets.org/disease/HP_0002315",
				"Phase": "Phase 4",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT03997006"],
				"Sponsor": "Damanhour Teaching Hospital"
			},
			{
				"Drug": "THEOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL190",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "Bronchiectasis",
				"Disease URL": "https://platform.opentargets.org/disease/HP_0002110",
				"Phase": "Phase 4",
				"Status": "Completed",
				"Source URLs": [
					"https://clinicaltrials.gov/study/NCT01684683",
					"https://clinicaltrials.gov/study/NCT01769898"
				],
				"Sponsor": "The First Affiliated Hospital of Guangzhou Medical University"
			},
			{
				"Drug": "OXTRIPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL1200434",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "Airway obstruction",
				"Disease URL": "https://platform.opentargets.org/disease/HP_0006536",
				"Phase": "Phase 4",
				"Status": "N/A",
				"Source URLs": ["https://www.whocc.no/atc_ddd_index/?code=R03DA02"],
				"Sponsor": "Unknown"
			},
			{
				"Drug": "ADENOSINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL477",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor agonist",
				"Disease": "cardiovascular disease",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0000319",
				"Phase": "Phase 4",
				"Status": "N/A",
				"Source URLs": ["https://www.whocc.no/atc_ddd_index/?code=C01EB10"],
				"Sponsor": "Unknown"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "cognition",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0003925",
				"Phase": "Phase 4",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT00981955"],
				"Sponsor": "Northumbria University"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "energy expenditure",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0005109",
				"Phase": "Phase 4",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT00781586"],
				"Sponsor": "Bayer"
			},
			{
				"Drug": "THEOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL190",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "Headache",
				"Disease URL": "https://platform.opentargets.org/disease/HP_0002315",
				"Phase": "Phase 4",
				"Status": "Completed",
				"Source URLs": [
					"https://clinicaltrials.gov/study/NCT03997006",
					"https://clinicaltrials.gov/study/NCT04257851"
				],
				"Sponsor": "Damanhour Teaching Hospital"
			},
			{
				"Drug": "ADENOSINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL477",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor agonist",
				"Disease": "Takotsubo cardiomyopathy",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_1002000",
				"Phase": "Phase 2",
				"Status": "Terminated",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT02867878"],
				"Sponsor": "University Hospital of Ferrara"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "cocaine dependence",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0002610",
				"Phase": "Phase 2",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT00495092"],
				"Sponsor": "Hospital Universitari Vall d&#x27;Hebron Research Institute"
			},
			{
				"Drug": "ADENOSINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL477",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor agonist",
				"Disease": "Wolff-Parkinson-White Syndrome",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_1001450",
				"Phase": "Phase 4",
				"Status": "N/A",
				"Source URLs": [
					"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8f433e01-8554-4b05-84b1-d21c21ba68bd",
					"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aef664c9-d1e6-4d1a-b127-3326bdc47b7e",
					"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5a55b45d-9cee-4c0c-9e44-021dbf70a018",
					"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=356dac0f-258b-48a4-b7de-528ba2d241c8",
					"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee89d63b-123d-4995-b7cc-822c5bee16aa",
					"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3c04c033-72e5-469e-83ec-0182cad8be6e",
					"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ab2edabd-e57d-4754-9822-93bd17af9e88",
					"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a68d1eff-5cbb-4a6e-98e7-0fb6590ce2a0"
				],
				"Sponsor": "Unknown"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "ischemia reperfusion injury",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0002687",
				"Phase": "Phase 4",
				"Status": "Completed",
				"Source URLs": [
					"https://clinicaltrials.gov/study/NCT00430170",
					"https://clinicaltrials.gov/study/NCT01610401"
				],
				"Sponsor": "Radboud University Medical Center"
			},
			{
				"Drug": "THEOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL190",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "kidney failure",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_1002048",
				"Phase": "Phase 4",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT00492518"],
				"Sponsor": "Technical University of Munich"
			},
			{
				"Drug": "CAFFEINE CITRATE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL1200569",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "Apnea",
				"Disease URL": "https://platform.opentargets.org/disease/HP_0002104",
				"Phase": "Phase 4",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT04868565"],
				"Sponsor": "Children&#x27;s Hospital of Chongqing Medical University"
			},
			{
				"Drug": "THEOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL190",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "chronic bronchitis",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0006505",
				"Phase": "Phase 4",
				"Status": "N/A",
				"Source URLs": [
					"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c3bb34c1-89b2-48c3-9ad2-16b4b2bce5f9",
					"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=02fcc06e-2a81-404f-a7cd-313fcb0d833c"
				],
				"Sponsor": "Unknown"
			},
			{
				"Drug": "ADENOSINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL477",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor agonist",
				"Disease": "paroxysmal tachycardia",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0009493",
				"Phase": "Phase 4",
				"Status": "N/A",
				"Source URLs": [
					"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=356dac0f-258b-48a4-b7de-528ba2d241c8",
					"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b4a82bd5-74d9-427f-a6b5-95d02c660447",
					"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5bca8860-de02-4c7f-bb43-01dfe4aea139",
					"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b827e3f8-dd63-4e54-90f4-0eded943de9f",
					"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3d8fc3cd-6ff4-4ee3-98cb-1875775bbbe6",
					"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aef664c9-d1e6-4d1a-b127-3326bdc47b7e",
					"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a68d1eff-5cbb-4a6e-98e7-0fb6590ce2a0",
					"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=45faaa70-54cf-4f82-bf7e-8bdd3865e1d6",
					"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5a55b45d-9cee-4c0c-9e44-021dbf70a018",
					"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8f433e01-8554-4b05-84b1-d21c21ba68bd",
					"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ca4520ad-7f42-4632-8065-5b88a0ca7f2f",
					"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ab2edabd-e57d-4754-9822-93bd17af9e88",
					"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3c04c033-72e5-469e-83ec-0182cad8be6e",
					"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f0e32589-dad9-4887-8481-bcf7f6618466",
					"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f3fa566a-d2d8-4d73-b8bf-33ad0f4ca746",
					"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee89d63b-123d-4995-b7cc-822c5bee16aa",
					"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e660f71c-35ed-438e-8505-4538f5e925a2"
				],
				"Sponsor": "Unknown"
			},
			{
				"Drug": "ADENOSINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL477",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor agonist",
				"Disease": "ventricular ectopy",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0009276",
				"Phase": "Phase 4",
				"Status": "Recruiting",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT03218137"],
				"Sponsor": "Weill Medical College of Cornell University"
			},
			{
				"Drug": "AMINOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL1370561",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "asthma",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0004979",
				"Phase": "Phase 3",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT00442338"],
				"Sponsor": "Organon and Co"
			},
			{
				"Drug": "AMINOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL1370561",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "Airway obstruction",
				"Disease URL": "https://platform.opentargets.org/disease/HP_0006536",
				"Phase": "Phase 4",
				"Status": "N/A",
				"Source URLs": [
					"https://www.whocc.no/atc_ddd_index/?code=R03DA05",
					"https://www.whocc.no/atc_ddd_index/?code=R03DA55"
				],
				"Sponsor": "Unknown"
			},
			{
				"Drug": "ADENOSINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL477",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor agonist",
				"Disease": "Supraventricular tachycardia",
				"Disease URL": "https://platform.opentargets.org/disease/HP_0004755",
				"Phase": "Phase 4",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT00413712"],
				"Sponsor": "Singapore General Hospital"
			},
			{
				"Drug": "THEOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL190",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "Airway obstruction",
				"Disease URL": "https://platform.opentargets.org/disease/HP_0006536",
				"Phase": "Phase 4",
				"Status": "N/A",
				"Source URLs": [
					"https://www.whocc.no/atc_ddd_index/?code=R03DA02",
					"https://www.whocc.no/atc_ddd_index/?code=R03DA04",
					"https://www.whocc.no/atc_ddd_index/?code=R03DA55",
					"https://www.whocc.no/atc_ddd_index/?code=R03DA05",
					"https://www.whocc.no/atc_ddd_index/?code=R03DA54",
					"https://www.whocc.no/atc_ddd_index/?code=R03DA74"
				],
				"Sponsor": "Unknown"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "ulcerative colitis",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0000729",
				"Phase": "Phase 1",
				"Status": "Suspended",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT03358706"],
				"Sponsor": "Janssen Research &amp; Development, LLC"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "idiopathic scoliosis",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0000726",
				"Phase": "Phase 4",
				"Status": "Recruiting",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT04950660"],
				"Sponsor": "Children&#x27;s Mercy Hospital Kansas City"
			},
			{
				"Drug": "THEOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL190",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "chronic obstructive pulmonary disease",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0000341",
				"Phase": "Phase 4",
				"Status": "Completed",
				"Source URLs": [
					"https://clinicaltrials.gov/study/NCT01415518",
					"https://clinicaltrials.gov/study/NCT01010178",
					"https://clinicaltrials.gov/study/NCT02261727"
				],
				"Sponsor": "AstraZeneca"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "Crohn's disease",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0000384",
				"Phase": "Phase 1",
				"Status": "Suspended",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT03358706"],
				"Sponsor": "Janssen Research &amp; Development, LLC"
			},
			{
				"Drug": "THEOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL190",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "Acute kidney injury",
				"Disease URL": "https://platform.opentargets.org/disease/HP_0001919",
				"Phase": "Phase 4",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01594489"],
				"Sponsor": "Ospedale Misericordia e Dolce"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "coronary artery disease",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0001645",
				"Phase": "Phase 3",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT00564824"],
				"Sponsor": "Sheba Medical Center"
			},
			{
				"Drug": "ADENOSINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL477",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor agonist",
				"Disease": "hypertension",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0000537",
				"Phase": "Phase 4",
				"Status": "Terminated",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01918111"],
				"Sponsor": "Yonsei University"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "attention deficit hyperactivity disorder",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0003888",
				"Phase": "Phase 0.5",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT03533556"],
				"Sponsor": "Texas Tech University"
			},
			{
				"Drug": "ADENOSINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL477",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor agonist",
				"Disease": "acute coronary syndrome",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0005672",
				"Phase": "Phase 4",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT04699110"],
				"Sponsor": "National Institute of Cardiovascular Diseases, Pakistan"
			},
			{
				"Drug": "CAFFEINE CITRATE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL1200569",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "premature birth",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0003917",
				"Phase": "Phase 3",
				"Status": "Completed",
				"Source URLs": [
					"https://clinicaltrials.gov/study/NCT04001712",
					"https://clinicaltrials.gov/study/NCT02103777"
				],
				"Sponsor": "Ain Shams University"
			},
			{
				"Drug": "ADENOSINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL477",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor agonist",
				"Disease": "angina pectoris",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0003913",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01123525"],
				"Sponsor": "University Hospital of North Norway"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "Low back pain",
				"Disease URL": "https://platform.opentargets.org/disease/HP_0003419",
				"Phase": "Phase 3",
				"Status": "Unknown status",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT02985671"],
				"Sponsor": "Ache Laboratorios Farmaceuticos S.A."
			},
			{
				"Drug": "PICLIDENOSON",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL3989873",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine A3 receptor agonist",
				"Disease": "rheumatoid arthritis",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0000685",
				"Phase": "Phase 2",
				"Status": "Completed",
				"Source URLs": [
					"https://clinicaltrials.gov/study/NCT00280917",
					"https://clinicaltrials.gov/study/NCT01034306",
					"https://clinicaltrials.gov/study/NCT00556894"
				],
				"Sponsor": "Can-Fite BioPharma"
			},
			{
				"Drug": "ADENOSINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL477",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor agonist",
				"Disease": "atrial fibrillation",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0000275",
				"Phase": "Phase 3",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01932112"],
				"Sponsor": "Seoul St. Mary&#x27;s Hospital"
			},
			{
				"Drug": "ADENOSINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL477",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor agonist",
				"Disease": "Myocardial Ischemia",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_1001375",
				"Phase": "Phase 3",
				"Status": "Not yet recruiting",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT05014061"],
				"Sponsor": "Vastra Gotaland Region"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "migraine without aura",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0100431",
				"Phase": "Phase 3",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT00471952"],
				"Sponsor": "Diamond Headache Clinic"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "Alzheimer disease",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0004975",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": [
					"https://clinicaltrials.gov/study/NCT00726726",
					"https://clinicaltrials.gov/study/NCT00692510"
				],
				"Sponsor": "Bristol-Myers Squibb"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "atrial fibrillation",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0000275",
				"Phase": "Phase 3",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01999829"],
				"Sponsor": "Assistance Publique Hopitaux De Marseille"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "bronchopulmonary dysplasia",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0019091",
				"Phase": "Phase 3",
				"Status": "Recruiting",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT05682807"],
				"Sponsor": "Tanta University"
			},
			{
				"Drug": "ADENOSINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL477",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor agonist",
				"Disease": "ventricular tachycardia",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0005306",
				"Phase": "Phase 3",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT04392362"],
				"Sponsor": "University of Pretoria"
			},
			{
				"Drug": "PICLIDENOSON",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL3989873",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine A3 receptor agonist",
				"Disease": "dry eye syndrome",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_1000906",
				"Phase": "Phase 3",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01235234"],
				"Sponsor": "Can-Fite BioPharma"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "toothache",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0010072",
				"Phase": "Phase 3",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT05485805"],
				"Sponsor": "Bayer"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "intermittent vascular claudication",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0003876",
				"Phase": "Phase 3",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT00388128"],
				"Sponsor": "University of Aarhus"
			},
			{
				"Drug": "ADENOSINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL477",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor agonist",
				"Disease": "coronary stenosis",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0006715",
				"Phase": "Phase 3",
				"Status": "Terminated",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT00612521"],
				"Sponsor": "Ottawa Heart Institute Research Corporation"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "hypoxia",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0009444",
				"Phase": "Phase 3",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01875159"],
				"Sponsor": "American SIDS Institute"
			},
			{
				"Drug": "ADENOSINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL477",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor agonist",
				"Disease": "cancer",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0004992",
				"Phase": "Phase 3",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT00565188"],
				"Sponsor": "Maastricht University Medical Center"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "obesity",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0001073",
				"Phase": "Phase 3",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT02048215"],
				"Sponsor": "Istituto Auxologico Italiano"
			},
			{
				"Drug": "THEOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL190",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "respiratory failure",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0009686",
				"Phase": "Phase 3",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT00003684"],
				"Sponsor": "Canadian Cancer Trials Group"
			},
			{
				"Drug": "ADENOSINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL477",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor agonist",
				"Disease": "acute myocardial infarction",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0008583",
				"Phase": "Phase 3",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT00781404"],
				"Sponsor": "Hospital Universitari Vall d&#x27;Hebron Research Institute"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "migraine with aura",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0005475",
				"Phase": "Phase 3",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT00471952"],
				"Sponsor": "Diamond Headache Clinic"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "Parkinson disease",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0005180",
				"Phase": "Phase 3",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01738178"],
				"Sponsor": "McGill University Health Centre&#x2F;Research Institute of the McGill University Health Centre"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "Back pain",
				"Disease URL": "https://platform.opentargets.org/disease/HP_0003418",
				"Phase": "Phase 3",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT03003000"],
				"Sponsor": "Boehringer Ingelheim"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "Dysmenorrhea",
				"Disease URL": "https://platform.opentargets.org/disease/HP_0100607",
				"Phase": "Phase 3",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01462370"],
				"Sponsor": "Organon and Co"
			},
			{
				"Drug": "PICLIDENOSON",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL3989873",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine A3 receptor agonist",
				"Disease": "psoriasis",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0000676",
				"Phase": "Phase 3",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT03168256"],
				"Sponsor": "Can-Fite BioPharma"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "premature birth",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0003917",
				"Phase": "Phase 3",
				"Status": "Completed",
				"Source URLs": [
					"https://clinicaltrials.gov/study/NCT04001712",
					"https://clinicaltrials.gov/study/NCT02103777"
				],
				"Sponsor": "Ain Shams University"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "relapsing-remitting multiple sclerosis",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0003929",
				"Phase": "Phase 3",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01462318"],
				"Sponsor": "Biogen"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "Neck pain",
				"Disease URL": "https://platform.opentargets.org/disease/HP_0030833",
				"Phase": "Phase 3",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT03003000"],
				"Sponsor": "Boehringer Ingelheim"
			},
			{
				"Drug": "CAFFEINE CITRATE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL1200569",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "ileus",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0004567",
				"Phase": "Phase 2",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT03097900"],
				"Sponsor": "Hadassah Medical Organization"
			},
			{
				"Drug": "NAMODENOSON",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL431733",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine A3 receptor agonist",
				"Disease": "non-alcoholic steatohepatitis",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_1001249",
				"Phase": "Phase 2",
				"Status": "Recruiting",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT04697810"],
				"Sponsor": "Can-Fite BioPharma"
			},
			{
				"Drug": "ADENOSINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL477",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor agonist",
				"Disease": "acute respiratory distress syndrome",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_1000637",
				"Phase": "Phase 2",
				"Status": "Not yet recruiting",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT04588441"],
				"Sponsor": "University of Florida"
			},
			{
				"Drug": "ADENOSINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL477",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor agonist",
				"Disease": "coronary artery disease",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0001645",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01690884"],
				"Sponsor": "Vanderbilt University Medical Center"
			},
			{
				"Drug": "THEOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL190",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "kidney disease",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0003086",
				"Phase": "Phase 2",
				"Status": "Unknown status",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT02088502"],
				"Sponsor": "Isfahan University of Medical Sciences"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "ileus",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0004567",
				"Phase": "Phase 2",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT03097900"],
				"Sponsor": "Hadassah Medical Organization"
			},
			{
				"Drug": "THEOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL190",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "Albright hereditary osteodystrophy",
				"Disease URL": "https://platform.opentargets.org/disease/Orphanet_665",
				"Phase": "Phase 2",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT02463409"],
				"Sponsor": "Vanderbilt University Medical Center"
			},
			{
				"Drug": "CAFFEINE CITRATE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL1200569",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "Encephalopathy",
				"Disease URL": "https://platform.opentargets.org/disease/HP_0001298",
				"Phase": "Phase 2",
				"Status": "Recruiting",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT05232734"],
				"Sponsor": "Singapore General Hospital"
			},
			{
				"Drug": "NAMODENOSON",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL431733",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine A3 receptor agonist",
				"Disease": "non-alcoholic fatty liver disease",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0003095",
				"Phase": "Phase 2",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT02927314"],
				"Sponsor": "Can-Fite BioPharma"
			},
			{
				"Drug": "THEOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL190",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "pseudohypoparathyroidism type 1A",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0007078",
				"Phase": "Phase 2",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT02463409"],
				"Sponsor": "Vanderbilt University Medical Center"
			},
			{
				"Drug": "ADENOSINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL477",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor agonist",
				"Disease": "ST Elevation Myocardial Infarction",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0008585",
				"Phase": "Phase 2",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01747174"],
				"Sponsor": "University Hospitals, Leicester"
			},
			{
				"Drug": "THEOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL190",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "cardiac arrest",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0009492",
				"Phase": "Phase 2",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT00312273"],
				"Sponsor": "Vancouver General Hospital"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "cellulitis",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0003035",
				"Phase": "Phase 2",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT03556917"],
				"Sponsor": "Universidade Norte do Paran"
			},
			{
				"Drug": "CAFFEINE CITRATE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL1200569",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "retinopathy of prematurity",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_1001158",
				"Phase": "Phase 2",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT02344225"],
				"Sponsor": "State University of New York - Downstate Medical Center"
			},
			{
				"Drug": "AMINOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL1370561",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "cardiac arrest",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0009492",
				"Phase": "Phase 2",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT00312273"],
				"Sponsor": "Vancouver General Hospital"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "Dyspnea",
				"Disease URL": "https://platform.opentargets.org/disease/HP_0002094",
				"Phase": "Phase 2",
				"Status": "Terminated",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT02311088"],
				"Sponsor": "Uppsala University"
			},
			{
				"Drug": "THEOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL190",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "viral disease",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0000763",
				"Phase": "Phase 2",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT03990766"],
				"Sponsor": "Washington University School of Medicine"
			},
			{
				"Drug": "THEOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL190",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "altitude sickness",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_1000782",
				"Phase": "Phase 2",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01902758"],
				"Sponsor": "University of Montana"
			},
			{
				"Drug": "NAMODENOSON",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL431733",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine A3 receptor agonist",
				"Disease": "hepatocellular carcinoma",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0000182",
				"Phase": "Phase 2",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT02128958"],
				"Sponsor": "Can-Fite BioPharma"
			},
			{
				"Drug": "ADENOSINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL477",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor agonist",
				"Disease": "myocardial infarction",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0000612",
				"Phase": "Phase 2",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT00590070"],
				"Sponsor": "Catholic University of the Sacred Heart"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "Tension-type headache",
				"Disease URL": "https://platform.opentargets.org/disease/HP_0012228",
				"Phase": "Phase 2",
				"Status": "Terminated",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01755702"],
				"Sponsor": "GlaxoSmithKline"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "Encephalopathy",
				"Disease URL": "https://platform.opentargets.org/disease/HP_0001298",
				"Phase": "Phase 2",
				"Status": "Recruiting",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT05232734"],
				"Sponsor": "Singapore General Hospital"
			},
			{
				"Drug": "ADENOSINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL477",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor agonist",
				"Disease": "pain",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0003843",
				"Phase": "Phase 2",
				"Status": "Completed",
				"Source URLs": [
					"https://clinicaltrials.gov/study/NCT00349921",
					"https://clinicaltrials.gov/study/NCT00298636"
				],
				"Sponsor": "Wake Forest University Health Sciences"
			},
			{
				"Drug": "THEOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL190",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "pseudohypoparathyroidism",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0019992",
				"Phase": "Phase 2",
				"Status": "Recruiting",
				"Source URLs": [
					"https://clinicaltrials.gov/study/NCT03029429",
					"https://clinicaltrials.gov/study/NCT04551170"
				],
				"Sponsor": "Vanderbilt University Medical Center"
			},
			{
				"Drug": "PICLIDENOSON",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL3989873",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine A3 receptor agonist",
				"Disease": "intermediate uveitis",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_1000986",
				"Phase": "Phase 2",
				"Status": "Withdrawn",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01905124"],
				"Sponsor": "Can-Fite BioPharma"
			},
			{
				"Drug": "PICLIDENOSON",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL3989873",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine A3 receptor agonist",
				"Disease": "ocular hypertension",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_1001069",
				"Phase": "Phase 2",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01033422"],
				"Sponsor": "Can-Fite BioPharma"
			},
			{
				"Drug": "PICLIDENOSON",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL3989873",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine A3 receptor agonist",
				"Disease": "osteoarthritis, knee",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0004616",
				"Phase": "Phase 2",
				"Status": "Withdrawn",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT00837291"],
				"Sponsor": "Can-Fite BioPharma"
			},
			{
				"Drug": "PICLIDENOSON",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL3989873",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine A3 receptor agonist",
				"Disease": "glaucoma",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0005041",
				"Phase": "Phase 2",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01033422"],
				"Sponsor": "Can-Fite BioPharma"
			},
			{
				"Drug": "THEOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL190",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "congenital heart disease",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0005207",
				"Phase": "Phase 2",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT05717049"],
				"Sponsor": "Oslo University Hospital"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "breast carcinoma",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0000305",
				"Phase": "Phase 2",
				"Status": "Active, not recruiting",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT03768492"],
				"Sponsor": "NYU Langone Health"
			},
			{
				"Drug": "PICLIDENOSON",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL3989873",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine A3 receptor agonist",
				"Disease": "COVID-19",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0100096",
				"Phase": "Phase 2",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT04333472"],
				"Sponsor": "Can-Fite BioPharma"
			},
			{
				"Drug": "ADENOSINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL477",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor agonist",
				"Disease": "cardiomyopathy",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0000318",
				"Phase": "Phase 2",
				"Status": "Unknown status",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT02681913"],
				"Sponsor": "Amphia Hospital"
			},
			{
				"Drug": "THEOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL190",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "Apnea",
				"Disease URL": "https://platform.opentargets.org/disease/HP_0002104",
				"Phase": "Phase 2",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01066728"],
				"Sponsor": "University of Manitoba"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "Spinal cord injury",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_1001919",
				"Phase": "Phase 2",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT02323698"],
				"Sponsor": "Spaulding Rehabilitation Hospital"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "retinopathy of prematurity",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_1001158",
				"Phase": "Phase 2",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT02344225"],
				"Sponsor": "State University of New York - Downstate Medical Center"
			},
			{
				"Drug": "THEOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL190",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "leukemia",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0000565",
				"Phase": "Phase 2",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT00003808"],
				"Sponsor": "Eastern Cooperative Oncology Group"
			},
			{
				"Drug": "CAFFEINE CITRATE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL1200569",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "pain",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0003843",
				"Phase": "Phase 0.5",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT03577730"],
				"Sponsor": "University of Michigan"
			},
			{
				"Drug": "THEOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL190",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "COVID-19",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0100096",
				"Phase": "Phase 2",
				"Status": "Recruiting",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT05947643"],
				"Sponsor": "Washington University School of Medicine"
			},
			{
				"Drug": "PICLIDENOSON",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL3989873",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine A3 receptor agonist",
				"Disease": "posterior uveitis",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_1001119",
				"Phase": "Phase 2",
				"Status": "Withdrawn",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01905124"],
				"Sponsor": "Can-Fite BioPharma"
			},
			{
				"Drug": "AMINOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL1370561",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "premature birth",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0003917",
				"Phase": "Phase 1",
				"Status": "Unknown status",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT03152942"],
				"Sponsor": "St Stephens Aids Trust"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "brain ischemia",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0005299",
				"Phase": "Phase 1",
				"Status": "Active, not recruiting",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT03913221"],
				"Sponsor": "University of North Carolina, Chapel Hill"
			},
			{
				"Drug": "ADENOSINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL477",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor agonist",
				"Disease": "leukemia",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0000565",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT00714103"],
				"Sponsor": "M.D. Anderson Cancer Center"
			},
			{
				"Drug": "CAFFEINE CITRATE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL1200569",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "liver disease",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0001421",
				"Phase": "Phase 1",
				"Status": "Withdrawn",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT02098785"],
				"Sponsor": "University of Birmingham"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "atopic eczema",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0000274",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": [
					"https://clinicaltrials.gov/study/NCT02647086",
					"https://clinicaltrials.gov/study/NCT03556592"
				],
				"Sponsor": "Regeneron Pharmaceuticals"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "COVID-19",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0100096",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT05594615"],
				"Sponsor": "Enanta Pharmaceuticals, Inc"
			},
			{
				"Drug": "ADENOSINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL477",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor agonist",
				"Disease": "ischemia",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0000556",
				"Phase": "Phase 1",
				"Status": "Terminated",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT00179010"],
				"Sponsor": "Vanderbilt University Medical Center"
			},
			{
				"Drug": "THEOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL190",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "prostate carcinoma",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0001663",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01017939"],
				"Sponsor": "Janssen Research &amp; Development, LLC"
			},
			{
				"Drug": "THEOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL190",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "non-small cell lung carcinoma",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0003060",
				"Phase": "Phase 1",
				"Status": "Terminated",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT02080078"],
				"Sponsor": "AHS Cancer Control Alberta"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "type 2 diabetes mellitus",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0005148",
				"Phase": "Phase 0.5",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT00432887"],
				"Sponsor": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "prostate cancer",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0008315",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT02225093"],
				"Sponsor": "Astellas Pharma Inc"
			},
			{
				"Drug": "ADENOSINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL477",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor agonist",
				"Disease": "neoplasm",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0000616",
				"Phase": "Phase 1",
				"Status": "Unknown status",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT00845689"],
				"Sponsor": "Ludwig-Maximilians - University of Munich"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "narcolepsy",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0021107",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT02832336"],
				"Sponsor": "King Saud University"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "metastatic melanoma",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0002617",
				"Phase": "Phase 1",
				"Status": "Active, not recruiting",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT03864042"],
				"Sponsor": "Pfizer"
			},
			{
				"Drug": "AMINOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL1370561",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "altitude sickness",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_1000782",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": [
					"https://clinicaltrials.gov/study/NCT01587027",
					"https://clinicaltrials.gov/study/NCT01794078"
				],
				"Sponsor": "Poudre Valley Health System"
			},
			{
				"Drug": "AMINOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL1370561",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "pulmonary arterial hypertension",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0001361",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01530464"],
				"Sponsor": "Duke University"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "chronic hepatitis C virus infection",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0004220",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01525628"],
				"Sponsor": "Boehringer Ingelheim"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "Chronic pain",
				"Disease URL": "https://platform.opentargets.org/disease/HP_0012532",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT00930306"],
				"Sponsor": "AstraZeneca"
			},
			{
				"Drug": "THEOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL190",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "acute myeloid leukemia",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0000222",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT00175812"],
				"Sponsor": "University of Bergen"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "serum lipopolysaccharide activity",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0600064",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT00513110"],
				"Sponsor": "Radboud University Medical Center"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "amblyopia",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0001020",
				"Phase": "Phase 1",
				"Status": "Withdrawn",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT02594358"],
				"Sponsor": "Johns Hopkins University"
			},
			{
				"Drug": "NAMODENOSON",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL431733",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine A3 receptor agonist",
				"Disease": "chronic hepatitis C virus infection",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0004220",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT00790673"],
				"Sponsor": "Can-Fite BioPharma"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "rheumatoid arthritis",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0000685",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": [
					"https://clinicaltrials.gov/study/NCT03131973",
					"https://clinicaltrials.gov/study/NCT04246762",
					"https://clinicaltrials.gov/study/NCT01636557"
				],
				"Sponsor": "Bristol-Myers Squibb"
			},
			{
				"Drug": "THEOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL190",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "pulmonary arterial hypertension",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0001361",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": [
					"https://clinicaltrials.gov/study/NCT01566565",
					"https://clinicaltrials.gov/study/NCT01530464"
				],
				"Sponsor": "Norwegian Armed Forces Medical Service"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "liver disease",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0001421",
				"Phase": "Phase 1",
				"Status": "Withdrawn",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT02098785"],
				"Sponsor": "University of Birmingham"
			},
			{
				"Drug": "CAFFEINE CITRATE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL1200569",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "brain ischemia",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0005299",
				"Phase": "Phase 1",
				"Status": "Active, not recruiting",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT03913221"],
				"Sponsor": "University of North Carolina, Chapel Hill"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "HIV infection",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0000764",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT04425902"],
				"Sponsor": "ViiV Healthcare"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "alcohol dependence",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0007079",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01289561"],
				"Sponsor": "Johns Hopkins University"
			},
			{
				"Drug": "ADENOSINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL477",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor agonist",
				"Disease": "inflammation",
				"Disease URL": "https://platform.opentargets.org/disease/MP_0001845",
				"Phase": "Phase 1",
				"Status": "Terminated",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT00580905"],
				"Sponsor": "Vanderbilt University Medical Center"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "amyotrophic lateral sclerosis",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0004976",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT02655614"],
				"Sponsor": "Genentech, Inc."
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "sexual dysfunction",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0004714",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT05685407"],
				"Sponsor": "University of Texas at Austin"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "orthostatic hypotension",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0005252",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT00223691"],
				"Sponsor": "Vanderbilt University Medical Center"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "metastasis",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0009708",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT02688088"],
				"Sponsor": "Eli Lilly and Company"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "substance dependence",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0004938",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT00437632"],
				"Sponsor": "GlaxoSmithKline"
			},
			{
				"Drug": "THEOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL190",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "major depressive disorder",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0002009",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01263106"],
				"Sponsor": "Eli Lilly and Company"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "non-alcoholic steatohepatitis",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_1001249",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT03187496"],
				"Sponsor": "Enanta Pharmaceuticals, Inc"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "anemia (phenotype)",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0004272",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT00443170"],
				"Sponsor": "GlaxoSmithKline"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "melanoma",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0000756",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01001299"],
				"Sponsor": "Hoffmann-La Roche"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "psoriasis",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0000676",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": [
					"https://clinicaltrials.gov/study/NCT02772601",
					"https://clinicaltrials.gov/study/NCT03718884",
					"https://clinicaltrials.gov/study/NCT02397382",
					"https://clinicaltrials.gov/study/NCT02993471"
				],
				"Sponsor": "AbbVie"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "neoplasm",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0000616",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": [
					"https://clinicaltrials.gov/study/NCT02740712",
					"https://clinicaltrials.gov/study/NCT02520752",
					"https://clinicaltrials.gov/study/NCT01596647",
					"https://clinicaltrials.gov/study/NCT01517399",
					"https://clinicaltrials.gov/study/NCT03333824"
				],
				"Sponsor": "pharmaand GmbH"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "mitochondrial disease",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0044970",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT04643249"],
				"Sponsor": "Abliva AB"
			},
			{
				"Drug": "ADENOSINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL477",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor agonist",
				"Disease": "chronic lymphocytic leukemia",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0000095",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT00714103"],
				"Sponsor": "M.D. Anderson Cancer Center"
			},
			{
				"Drug": "THEOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL190",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "premature birth",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0003917",
				"Phase": "Phase 1",
				"Status": "Unknown status",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT03152942"],
				"Sponsor": "St Stephens Aids Trust"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "infectious disease",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0005741",
				"Phase": "Phase 1",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01275170"],
				"Sponsor": "Merck Sharp &amp; Dohme LLC"
			},
			{
				"Drug": "THEOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL190",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "lung cancer",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0008903",
				"Phase": "Phase 1",
				"Status": "Withdrawn",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01799161"],
				"Sponsor": "University of Miami"
			},
			{
				"Drug": "THEOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL190",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "depressive disorder",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0002050",
				"Phase": "Phase 0.5",
				"Status": "Withdrawn",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT04309877"],
				"Sponsor": "University of California, Los Angeles"
			},
			{
				"Drug": "CAFFEINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL113",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "voice disorders",
				"Disease URL": "https://platform.opentargets.org/disease/EFO_0009692",
				"Phase": "Phase 0.5",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01435837"],
				"Sponsor": "Southern Illinois University Carbondale"
			},
			{
				"Drug": "AMINOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL1370561",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "urinary bladder cancer",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0001187",
				"Phase": "Phase 0.5",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01240824"],
				"Sponsor": "University of Virginia"
			},
			{
				"Drug": "THEOPHYLLINE",
				"Drug URL": "https://platform.opentargets.org/drug/CHEMBL190",
				"Type": "Small molecule",
				"Mechanism of Action": "Adenosine receptor antagonist",
				"Disease": "urinary bladder cancer",
				"Disease URL": "https://platform.opentargets.org/disease/MONDO_0001187",
				"Phase": "Phase 0.5",
				"Status": "Completed",
				"Source URLs": ["https://clinicaltrials.gov/study/NCT01240824"],
				"Sponsor": "University of Virginia"
			}
		],
		"safety": {
			"Safety Events": [
				{
					"Safety Event": {
						"Event": "hypotension",
						"EventLink": "https://platform.opentargets.org/disease/EFO_0005251"
					},
					"Biosystems": [
						{
							"tissueLabel": "cardiovascular system",
							"tissueLink": "https://identifiers.org/UBERON:0004535"
						},
						{
							"tissueLabel": "immune",
							"tissueLink": "https://identifiers.org/UBERON:0002405"
						}
					],
					"Dosing Effect": {
						"Direction": "Activation/Increase/Upregulation",
						"Dosing": "general"
					},
					"Experimental Studies": "N/A",
					"Source": {
						"Source": "Urban et al. (2012)",
						"SourceURL": "https://doi.org/10.1002/9781118098141.ch2"
					}
				},
				{
					"Safety Event": {
						"Event": "proischemic (cerebral)",
						"EventLink": null
					},
					"Biosystems": [
						{
							"tissueLabel": "cardiovascular system",
							"tissueLink": "https://identifiers.org/UBERON:0004535"
						},
						{
							"tissueLabel": "immune",
							"tissueLink": "https://identifiers.org/UBERON:0002405"
						}
					],
					"Dosing Effect": {
						"Direction": "Activation/Increase/Upregulation",
						"Dosing": "general"
					},
					"Experimental Studies": "N/A",
					"Source": {
						"Source": "Urban et al. (2012)",
						"SourceURL": "https://doi.org/10.1002/9781118098141.ch2"
					}
				},
				{
					"Safety Event": {
						"Event": "decreased locomotor activity",
						"EventLink": "https://platform.opentargets.org/disease/GO_0040013"
					},
					"Biosystems": [
						{
							"tissueLabel": "nervous system",
							"tissueLink": "https://identifiers.org/UBERON:0001016"
						},
						{
							"tissueLabel": "respiratory",
							"tissueLink": "https://identifiers.org/UBERON:0001004"
						}
					],
					"Dosing Effect": {
						"Direction": "Activation/Increase/Upregulation",
						"Dosing": "acute"
					},
					"Experimental Studies": "N/A",
					"Source": {
						"Source": "Lynch et al. (2017)",
						"SourceURL": "https://europepmc.org/abstract/med/28216264"
					}
				},
				{
					"Safety Event": {
						"Event": "cell proliferation",
						"EventLink": "https://platform.opentargets.org/disease/GO_0008283"
					},
					"Biosystems": [
						{
							"tissueLabel": "cardiovascular system",
							"tissueLink": "https://identifiers.org/UBERON:0004535"
						},
						{
							"tissueLabel": "immune",
							"tissueLink": "https://identifiers.org/UBERON:0002405"
						}
					],
					"Dosing Effect": {
						"Direction": "Activation/Increase/Upregulation",
						"Dosing": "general"
					},
					"Experimental Studies": "N/A",
					"Source": {
						"Source": "Urban et al. (2012)",
						"SourceURL": "https://doi.org/10.1002/9781118098141.ch2"
					}
				},
				{
					"Safety Event": {
						"Event": "antiischaemic (cardioprotective)",
						"EventLink": null
					},
					"Biosystems": [
						{
							"tissueLabel": "cardiovascular system",
							"tissueLink": "https://identifiers.org/UBERON:0004535"
						},
						{
							"tissueLabel": "immune",
							"tissueLink": "https://identifiers.org/UBERON:0002405"
						}
					],
					"Dosing Effect": {
						"Direction": "Activation/Increase/Upregulation",
						"Dosing": "general"
					},
					"Experimental Studies": "N/A",
					"Source": {
						"Source": "Urban et al. (2012)",
						"SourceURL": "https://doi.org/10.1002/9781118098141.ch2"
					}
				},
				{
					"Safety Event": {
						"Event": "hypertension (inferred by author)",
						"EventLink": "https://platform.opentargets.org/disease/EFO_0000537"
					},
					"Biosystems": [
						{
							"tissueLabel": "cardiovascular system",
							"tissueLink": "https://identifiers.org/UBERON:0004535"
						},
						{
							"tissueLabel": "immune",
							"tissueLink": "https://identifiers.org/UBERON:0002405"
						}
					],
					"Dosing Effect": {
						"Direction": "Inhibition/Decrease/Downregulation",
						"Dosing": "general"
					},
					"Experimental Studies": "N/A",
					"Source": {
						"Source": "Urban et al. (2012)",
						"SourceURL": "https://doi.org/10.1002/9781118098141.ch2"
					}
				},
				{
					"Safety Event": {
						"Event": "interference with the regulation of cell growth (inferred by author)",
						"EventLink": null
					},
					"Biosystems": [
						{
							"tissueLabel": "cardiovascular system",
							"tissueLink": "https://identifiers.org/UBERON:0004535"
						},
						{
							"tissueLabel": "immune",
							"tissueLink": "https://identifiers.org/UBERON:0002405"
						}
					],
					"Dosing Effect": {
						"Direction": "Inhibition/Decrease/Downregulation",
						"Dosing": "general"
					},
					"Experimental Studies": "N/A",
					"Source": {
						"Source": "Urban et al. (2012)",
						"SourceURL": "https://doi.org/10.1002/9781118098141.ch2"
					}
				},
				{
					"Safety Event": {
						"Event": "cell necrosis",
						"EventLink": "https://platform.opentargets.org/disease/EFO_0009426"
					},
					"Biosystems": [
						{
							"tissueLabel": "cardiovascular system",
							"tissueLink": "https://identifiers.org/UBERON:0004535"
						},
						{
							"tissueLabel": "immune",
							"tissueLink": "https://identifiers.org/UBERON:0002405"
						}
					],
					"Dosing Effect": {
						"Direction": "Activation/Increase/Upregulation",
						"Dosing": "general"
					},
					"Experimental Studies": "N/A",
					"Source": {
						"Source": "Urban et al. (2012)",
						"SourceURL": "https://doi.org/10.1002/9781118098141.ch2"
					}
				},
				{
					"Safety Event": {
						"Event": "decreased pain",
						"EventLink": "https://platform.opentargets.org/disease/GO_1904057"
					},
					"Biosystems": [
						{
							"tissueLabel": "nervous system",
							"tissueLink": "https://identifiers.org/UBERON:0001016"
						},
						{
							"tissueLabel": "respiratory",
							"tissueLink": "https://identifiers.org/UBERON:0001004"
						}
					],
					"Dosing Effect": {
						"Direction": "Activation/Increase/Upregulation",
						"Dosing": "acute"
					},
					"Experimental Studies": "N/A",
					"Source": {
						"Source": "Lynch et al. (2017)",
						"SourceURL": "https://europepmc.org/abstract/med/28216264"
					}
				},
				{
					"Safety Event": {
						"Event": "decreased convulsions",
						"EventLink": "https://platform.opentargets.org/disease/EFO_0009853"
					},
					"Biosystems": [
						{
							"tissueLabel": "nervous system",
							"tissueLink": "https://identifiers.org/UBERON:0001016"
						},
						{
							"tissueLabel": "respiratory",
							"tissueLink": "https://identifiers.org/UBERON:0001004"
						}
					],
					"Dosing Effect": {
						"Direction": "Activation/Increase/Upregulation",
						"Dosing": "acute"
					},
					"Experimental Studies": "N/A",
					"Source": {
						"Source": "Lynch et al. (2017)",
						"SourceURL": "https://europepmc.org/abstract/med/28216264"
					}
				},
				{
					"Safety Event": {
						"Event": "immunosuppression",
						"EventLink": "https://platform.opentargets.org/disease/GO_0050777"
					},
					"Biosystems": [
						{
							"tissueLabel": "cardiovascular system",
							"tissueLink": "https://identifiers.org/UBERON:0004535"
						},
						{
							"tissueLabel": "immune",
							"tissueLink": "https://identifiers.org/UBERON:0002405"
						}
					],
					"Dosing Effect": {
						"Direction": "Activation/Increase/Upregulation",
						"Dosing": "general"
					},
					"Experimental Studies": "N/A",
					"Source": {
						"Source": "Urban et al. (2012)",
						"SourceURL": "https://doi.org/10.1002/9781118098141.ch2"
					}
				},
				{
					"Safety Event": {
						"Event": "increased bronchoconstriction",
						"EventLink": "https://platform.opentargets.org/disease/EFO_0009836"
					},
					"Biosystems": [
						{
							"tissueLabel": "nervous system",
							"tissueLink": "https://identifiers.org/UBERON:0001016"
						},
						{
							"tissueLabel": "respiratory",
							"tissueLink": "https://identifiers.org/UBERON:0001004"
						}
					],
					"Dosing Effect": {
						"Direction": "Activation/Increase/Upregulation",
						"Dosing": "acute"
					},
					"Experimental Studies": "N/A",
					"Source": {
						"Source": "Lynch et al. (2017)",
						"SourceURL": "https://europepmc.org/abstract/med/28216264"
					}
				},
				{
					"Safety Event": {
						"Event": "myocardial ischemia (inferred by author)",
						"EventLink": "https://platform.opentargets.org/disease/EFO_1001375"
					},
					"Biosystems": [
						{
							"tissueLabel": "cardiovascular system",
							"tissueLink": "https://identifiers.org/UBERON:0004535"
						},
						{
							"tissueLabel": "immune",
							"tissueLink": "https://identifiers.org/UBERON:0002405"
						}
					],
					"Dosing Effect": {
						"Direction": "Inhibition/Decrease/Downregulation",
						"Dosing": "general"
					},
					"Experimental Studies": "N/A",
					"Source": {
						"Source": "Urban et al. (2012)",
						"SourceURL": "https://doi.org/10.1002/9781118098141.ch2"
					}
				},
				{
					"Safety Event": {
						"Event": "increased convulsions",
						"EventLink": "https://platform.opentargets.org/disease/EFO_0009853"
					},
					"Biosystems": [
						{
							"tissueLabel": "nervous system",
							"tissueLink": "https://identifiers.org/UBERON:0001016"
						},
						{
							"tissueLabel": "respiratory",
							"tissueLink": "https://identifiers.org/UBERON:0001004"
						}
					],
					"Dosing Effect": {
						"Direction": "Inhibition/Decrease/Downregulation",
						"Dosing": "acute"
					},
					"Experimental Studies": "N/A",
					"Source": {
						"Source": "Lynch et al. (2017)",
						"SourceURL": "https://europepmc.org/abstract/med/28216264"
					}
				},
				{
					"Safety Event": {
						"Event": "proinflammatory effects (inferred by author)",
						"EventLink": "https://platform.opentargets.org/disease/GO_0050729"
					},
					"Biosystems": [
						{
							"tissueLabel": "cardiovascular system",
							"tissueLink": "https://identifiers.org/UBERON:0004535"
						},
						{
							"tissueLabel": "immune",
							"tissueLink": "https://identifiers.org/UBERON:0002405"
						}
					],
					"Dosing Effect": {
						"Direction": "Inhibition/Decrease/Downregulation",
						"Dosing": "general"
					},
					"Experimental Studies": "N/A",
					"Source": {
						"Source": "Urban et al. (2012)",
						"SourceURL": "https://doi.org/10.1002/9781118098141.ch2"
					}
				},
				{
					"Safety Event": {
						"Event": "angiogenesis",
						"EventLink": null
					},
					"Biosystems": [
						{
							"tissueLabel": "cardiovascular system",
							"tissueLink": "https://identifiers.org/UBERON:0004535"
						},
						{
							"tissueLabel": "immune",
							"tissueLink": "https://identifiers.org/UBERON:0002405"
						}
					],
					"Dosing Effect": {
						"Direction": "Activation/Increase/Upregulation",
						"Dosing": "general"
					},
					"Experimental Studies": "N/A",
					"Source": {
						"Source": "Urban et al. (2012)",
						"SourceURL": "https://doi.org/10.1002/9781118098141.ch2"
					}
				}
			]
		}
	},
	"target_prioritisation": {
		"targetability": {
			"Approved Symbol": "ADORA3",
			"Prioritisation": {
				"Target in clinic": 1,
				"Membrane protein": 1,
				"Secreted protein": 0,
				"Ligand binder": 1,
				"Small molecule binder": 1,
				"Predicted pockets": 0,
				"Mouse ortholog identity": 0,
				"Chemical probes": 0,
				"Genetic constraint": "no data",
				"Mouse models": -0.8270992553125023,
				"Gene essentiality": 0,
				"Known safety events": -1,
				"Cancer driver gene": "no data",
				"Paralogues": 0,
				"Tissue specificity": 0.5,
				"Tissue distribution": 0
			}
		},
		"tractability": {
			"Small molecule": {
				"Items": {
					"Approved Drug": {
						"Value": true,
						"Link": ""
					},
					"Advanced Clinical": {
						"Value": false,
						"Link": ""
					},
					"Phase 1 Clinical": {
						"Value": false,
						"Link": ""
					},
					"Structure with Ligand": {
						"Value": false,
						"Link": ""
					},
					"High-Quality Ligand": {
						"Value": true,
						"Link": ""
					},
					"High-Quality Pocket": {
						"Value": false,
						"Link": ""
					},
					"Med-Quality Pocket": {
						"Value": false,
						"Link": ""
					},
					"Druggable Family": {
						"Value": true,
						"Link": ""
					}
				},
				"Links": []
			},
			"Antibody": {
				"Items": {
					"Approved Drug": {
						"Value": false,
						"Link": ""
					},
					"Advanced Clinical": {
						"Value": false,
						"Link": ""
					},
					"Phase 1 Clinical": {
						"Value": false,
						"Link": ""
					},
					"UniProt loc high conf": {
						"Value": false,
						"Link": ""
					},
					"GO CC high conf": {
						"Value": true,
						"Link": ""
					},
					"UniProt loc med conf": {
						"Value": true,
						"Link": ""
					},
					"UniProt SigP or TMHMM": {
						"Value": true,
						"Link": ""
					},
					"GO CC med conf": {
						"Value": false,
						"Link": ""
					},
					"Human Protein Atlas loc": {
						"Value": false,
						"Link": ""
					}
				},
				"Links": []
			},
			"PROTAC": {
				"Items": {
					"Approved Drug": {
						"Value": false,
						"Link": ""
					},
					"Advanced Clinical": {
						"Value": false,
						"Link": ""
					},
					"Phase 1 Clinical": {
						"Value": false,
						"Link": ""
					},
					"Literature": {
						"Value": false,
						"Link": ""
					},
					"UniProt Ubiquitination": {
						"Value": false,
						"Link": ""
					},
					"Database Ubiquitination": {
						"Value": false,
						"Link": ""
					},
					"Half-life Data": {
						"Value": false,
						"Link": ""
					},
					"Small Molecule Binder": {
						"Value": true,
						"Link": ""
					}
				},
				"Links": []
			},
			"Other modalities": {
				"Items": {
					"Approved Drug": {
						"Value": false,
						"Link": ""
					},
					"Advanced Clinical": {
						"Value": false,
						"Link": ""
					},
					"Phase 1 Clinical": {
						"Value": false,
						"Link": ""
					}
				},
				"Links": []
			}
		}
	},
	"disease_association": [],
	"mouse_phenotypes": {
		"increased coronary flow rate": {
			"Gene": {
				"Name": "Adora3",
				"Link": "https://www.informatics.jax.org/marker/MGI:104847"
			},
			"Phenotype": {
				"Label": "increased coronary flow rate",
				"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/terms?obo_id=MP:0003022"
			},
			"Categories": [
				{
					"Label": "cardiovascular system phenotype",
					"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/classes?obo_id=MP:0005385"
				}
			],
			"Allelic Compositions": [
				{
					"Composition": "Adora3<tm1Jbsn>/Adora3<tm1Jbsn>",
					"Link": "https://www.informatics.jax.org/allele/genoview/MGI:4943461"
				}
			]
		},
		"decreased tumor necrosis factor secretion": {
			"Gene": {
				"Name": "Adora3",
				"Link": "https://www.informatics.jax.org/marker/MGI:104847"
			},
			"Phenotype": {
				"Label": "decreased tumor necrosis factor secretion",
				"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/terms?obo_id=MP:0008561"
			},
			"Categories": [
				{
					"Label": "immune system phenotype",
					"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/classes?obo_id=MP:0005387"
				}
			],
			"Allelic Compositions": [
				{
					"Composition": "Adora3<tm1Jbsn>/Adora3<tm1Jbsn>",
					"Link": "https://www.informatics.jax.org/allele/genoview/MGI:2653748"
				}
			]
		},
		"abnormal mast cell degranulation": {
			"Gene": {
				"Name": "Adora3",
				"Link": "https://www.informatics.jax.org/marker/MGI:104847"
			},
			"Phenotype": {
				"Label": "abnormal mast cell degranulation",
				"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/terms?obo_id=MP:0008763"
			},
			"Categories": [
				{
					"Label": "hematopoietic system phenotype",
					"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/classes?obo_id=MP:0005397"
				},
				{
					"Label": "immune system phenotype",
					"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/classes?obo_id=MP:0005387"
				},
				{
					"Label": "cellular phenotype",
					"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/classes?obo_id=MP:0005384"
				}
			],
			"Allelic Compositions": [
				{
					"Composition": "Adora3<tm1Jbsn>/Adora3<tm1Jbsn>",
					"Link": "https://www.informatics.jax.org/allele/genoview/MGI:4943477"
				}
			]
		},
		"impaired neutrophil recruitment": {
			"Gene": {
				"Name": "Adora3",
				"Link": "https://www.informatics.jax.org/marker/MGI:104847"
			},
			"Phenotype": {
				"Label": "impaired neutrophil recruitment",
				"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/terms?obo_id=MP:0008719"
			},
			"Categories": [
				{
					"Label": "hematopoietic system phenotype",
					"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/classes?obo_id=MP:0005397"
				},
				{
					"Label": "immune system phenotype",
					"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/classes?obo_id=MP:0005387"
				}
			],
			"Allelic Compositions": [
				{
					"Composition": "Adora3<tm1Jbsn>/Adora3<tm1Jbsn>",
					"Link": "https://www.informatics.jax.org/allele/genoview/MGI:4943477"
				}
			]
		},
		"decreased myocardial infarct size": {
			"Gene": {
				"Name": "Adora3",
				"Link": "https://www.informatics.jax.org/marker/MGI:104847"
			},
			"Phenotype": {
				"Label": "decreased myocardial infarct size",
				"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/terms?obo_id=MP:0003038"
			},
			"Categories": [
				{
					"Label": "homeostasis/metabolism phenotype",
					"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/classes?obo_id=MP:0005376"
				},
				{
					"Label": "cardiovascular system phenotype",
					"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/classes?obo_id=MP:0005385"
				}
			],
			"Allelic Compositions": [
				{
					"Composition": "Adora3<tm1Jbsn>/Adora3<tm1Jbsn>",
					"Link": "https://www.informatics.jax.org/allele/genoview/MGI:4943461"
				}
			]
		},
		"decreased systemic arterial blood pressure": {
			"Gene": {
				"Name": "Adora3",
				"Link": "https://www.informatics.jax.org/marker/MGI:104847"
			},
			"Phenotype": {
				"Label": "decreased systemic arterial blood pressure",
				"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/terms?obo_id=MP:0002843"
			},
			"Categories": [
				{
					"Label": "cardiovascular system phenotype",
					"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/classes?obo_id=MP:0005385"
				}
			],
			"Allelic Compositions": [
				{
					"Composition": "Adora3<tm1Jbsn>/Adora3<tm1Jbsn>",
					"Link": "https://www.informatics.jax.org/allele/genoview/MGI:4943461"
				}
			]
		},
		"decreased acute inflammation": {
			"Gene": {
				"Name": "Adora3",
				"Link": "https://www.informatics.jax.org/marker/MGI:104847"
			},
			"Phenotype": {
				"Label": "decreased acute inflammation",
				"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/terms?obo_id=MP:0005087"
			},
			"Categories": [
				{
					"Label": "immune system phenotype",
					"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/classes?obo_id=MP:0005387"
				}
			],
			"Allelic Compositions": [
				{
					"Composition": "Adora3<tm1Jbsn>/Adora3<tm1Jbsn>",
					"Link": "https://www.informatics.jax.org/allele/genoview/MGI:4943461"
				}
			]
		},
		"decreased susceptibility to kidney reperfusion injury": {
			"Gene": {
				"Name": "Adora3",
				"Link": "https://www.informatics.jax.org/marker/MGI:104847"
			},
			"Phenotype": {
				"Label": "decreased susceptibility to kidney reperfusion injury",
				"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/terms?obo_id=MP:0004042"
			},
			"Categories": [
				{
					"Label": "homeostasis/metabolism phenotype",
					"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/classes?obo_id=MP:0005376"
				},
				{
					"Label": "renal/urinary system phenotype",
					"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/classes?obo_id=MP:0005367"
				}
			],
			"Allelic Compositions": [
				{
					"Composition": "Adora3<tm1Jbsn>/Adora3<tm1Jbsn>",
					"Link": "https://www.informatics.jax.org/allele/genoview/MGI:4943477"
				}
			]
		},
		"abnormal response/metabolism to endogenous compounds": {
			"Gene": {
				"Name": "Adora3",
				"Link": "https://www.informatics.jax.org/marker/MGI:104847"
			},
			"Phenotype": {
				"Label": "abnormal response/metabolism to endogenous compounds",
				"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/terms?obo_id=MP:0003638"
			},
			"Categories": [
				{
					"Label": "homeostasis/metabolism phenotype",
					"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/classes?obo_id=MP:0005376"
				}
			],
			"Allelic Compositions": [
				{
					"Composition": "Adora3<tm1Jbsn>/Adora3<tm1Jbsn>",
					"Link": "https://www.informatics.jax.org/allele/genoview/MGI:4943477"
				},
				{
					"Composition": "Adora3<tm1Jbsn>/Adora3<tm1Jbsn>",
					"Link": "https://www.informatics.jax.org/allele/genoview/MGI:4943461"
				}
			]
		},
		"decreased mast cell degranulation": {
			"Gene": {
				"Name": "Adora3",
				"Link": "https://www.informatics.jax.org/marker/MGI:104847"
			},
			"Phenotype": {
				"Label": "decreased mast cell degranulation",
				"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/terms?obo_id=MP:0008765"
			},
			"Categories": [
				{
					"Label": "hematopoietic system phenotype",
					"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/classes?obo_id=MP:0005397"
				},
				{
					"Label": "immune system phenotype",
					"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/classes?obo_id=MP:0005387"
				},
				{
					"Label": "cellular phenotype",
					"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/classes?obo_id=MP:0005384"
				}
			],
			"Allelic Compositions": [
				{
					"Composition": "Adora3<tm1(ADORA3)Msth>/Adora3<tm1(ADORA3)Msth>",
					"Link": "https://www.informatics.jax.org/allele/genoview/MGI:3613463"
				}
			]
		},
		"abnormal nociception after inflammation": {
			"Gene": {
				"Name": "Adora3",
				"Link": "https://www.informatics.jax.org/marker/MGI:104847"
			},
			"Phenotype": {
				"Label": "abnormal nociception after inflammation",
				"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/terms?obo_id=MP:0002736"
			},
			"Categories": [
				{
					"Label": "behavior/neurological phenotype",
					"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/classes?obo_id=MP:0005386"
				}
			],
			"Allelic Compositions": [
				{
					"Composition": "Adora3<tm1Jbsn>/Adora3<tm1Jbsn>",
					"Link": "https://www.informatics.jax.org/allele/genoview/MGI:4943461"
				}
			]
		},
		"decreased circulating creatinine level": {
			"Gene": {
				"Name": "Adora3",
				"Link": "https://www.informatics.jax.org/marker/MGI:104847"
			},
			"Phenotype": {
				"Label": "decreased circulating creatinine level",
				"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/terms?obo_id=MP:0005554"
			},
			"Categories": [
				{
					"Label": "homeostasis/metabolism phenotype",
					"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/classes?obo_id=MP:0005376"
				}
			],
			"Allelic Compositions": [
				{
					"Composition": "Adora3<tm1Jbsn>/Adora3<tm1Jbsn>",
					"Link": "https://www.informatics.jax.org/allele/genoview/MGI:4943477"
				}
			]
		},
		"abnormal mast cell physiology": {
			"Gene": {
				"Name": "Adora3",
				"Link": "https://www.informatics.jax.org/marker/MGI:104847"
			},
			"Phenotype": {
				"Label": "abnormal mast cell physiology",
				"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/terms?obo_id=MP:0002423"
			},
			"Categories": [
				{
					"Label": "hematopoietic system phenotype",
					"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/classes?obo_id=MP:0005397"
				},
				{
					"Label": "immune system phenotype",
					"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/classes?obo_id=MP:0005387"
				}
			],
			"Allelic Compositions": [
				{
					"Composition": "Adora3<tm1Jbsn>/Adora3<tm1Jbsn>",
					"Link": "https://www.informatics.jax.org/allele/genoview/MGI:2653748"
				},
				{
					"Composition": "Adora3<tm1(ADORA3)Msth>/Adora3<tm1(ADORA3)Msth>",
					"Link": "https://www.informatics.jax.org/allele/genoview/MGI:3613463"
				}
			]
		},
		"decreased airway responsiveness": {
			"Gene": {
				"Name": "Adora3",
				"Link": "https://www.informatics.jax.org/marker/MGI:104847"
			},
			"Phenotype": {
				"Label": "decreased airway responsiveness",
				"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/terms?obo_id=MP:0002335"
			},
			"Categories": [
				{
					"Label": "respiratory system phenotype",
					"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/classes?obo_id=MP:0005388"
				}
			],
			"Allelic Compositions": [
				{
					"Composition": "Adora3<tm1Jbsn>/Adora3<tm1Jbsn>",
					"Link": "https://www.informatics.jax.org/allele/genoview/MGI:4943477"
				}
			]
		},
		"ocular hypotension": {
			"Gene": {
				"Name": "Adora3",
				"Link": "https://www.informatics.jax.org/marker/MGI:104847"
			},
			"Phenotype": {
				"Label": "ocular hypotension",
				"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/terms?obo_id=MP:0005260"
			},
			"Categories": [
				{
					"Label": "vision/eye phenotype",
					"Link": "https://www.ebi.ac.uk/ols4/ontologies/mp/classes?obo_id=MP:0005391"
				}
			],
			"Allelic Compositions": [
				{
					"Composition": "Adora3<tm1Jbsn>/Adora3<tm1Jbsn>",
					"Link": "https://www.informatics.jax.org/allele/genoview/MGI:4943477"
				}
			]
		}
	},
	"off_target_effects": {
		"human": [
			{
				"Species": "human",
				"Species ID": "9606",
				"Gene1 Symbol": "ADORA3",
				"Paralog Score": "3.40",
				"DIOPT Score": "4",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/2906284",
				"Gene2 Symbol": "ADORA1",
				"1-Protein Acc": "NP_000668",
				"2-Protein Acc": "NP_000665",
				"Alignment Length": "322",
				"Identity Score": "0.49",
				"Similarity Score": "0.69",
				"Common GO slim": "GO:0004871(signal transducer activity);GO:0005623(cell);GO:0007165(signal transduction)",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "mAChR-C(DIOPT=1,1);AdoR(DIOPT=5,7);",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0",
				"Coexpressed Samples": "2",
				"Tissue Expression Correlation": "0.16309",
				"Cell Line Expression Correlation": "-0.12740"
			},
			{
				"Species": "human",
				"Species ID": "9606",
				"Gene1 Symbol": "ADORA3",
				"Paralog Score": "3.12",
				"DIOPT Score": "4",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/2906286",
				"Gene2 Symbol": "ADORA2B",
				"1-Protein Acc": "NP_000668",
				"2-Protein Acc": "NP_000667",
				"Alignment Length": "315",
				"Identity Score": "0.39",
				"Similarity Score": "0.58",
				"Common GO slim": "GO:0004871(signal transducer activity);GO:0005623(cell);GO:0007165(signal transduction)",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "AdoR(DIOPT=5,8);mAChR-C(DIOPT=1,1);",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0",
				"Coexpressed Samples": "0",
				"Tissue Expression Correlation": "-0.25230",
				"Cell Line Expression Correlation": "-0.14580"
			},
			{
				"Species": "human",
				"Species ID": "9606",
				"Gene1 Symbol": "ADORA3",
				"Paralog Score": "3.04",
				"DIOPT Score": "4",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/2906285",
				"Gene2 Symbol": "ADORA2A",
				"1-Protein Acc": "NP_000668",
				"2-Protein Acc": "NP_000666",
				"Alignment Length": "336",
				"Identity Score": "0.39",
				"Similarity Score": "0.59",
				"Common GO slim": "GO:0004871(signal transducer activity);GO:0005623(cell);GO:0007165(signal transduction)",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "mAChR-C(DIOPT=1,1);AdoR(DIOPT=5,6);",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0",
				"Coexpressed Samples": "1",
				"Tissue Expression Correlation": "-0.12997",
				"Cell Line Expression Correlation": "0.05964"
			},
			{
				"Species": "human",
				"Species ID": "9606",
				"Gene1 Symbol": "ADORA3",
				"Paralog Score": "2.55",
				"DIOPT Score": "1",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/2906296",
				"Gene2 Symbol": "GPBAR1",
				"1-Protein Acc": "NP_000668",
				"2-Protein Acc": "NP_001070659",
				"Alignment Length": "355",
				"Identity Score": "0.20",
				"Similarity Score": "0.37",
				"Common GO slim": "GO:0004871(signal transducer activity);GO:0005623(cell);GO:0007165(signal transduction)",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "AdoR(DIOPT=5,1);",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0",
				"Coexpressed Samples": "0",
				"Tissue Expression Correlation": "0.10893",
				"Cell Line Expression Correlation": "0.01933"
			},
			{
				"Species": "human",
				"Species ID": "9606",
				"Gene1 Symbol": "ADORA3",
				"Paralog Score": "1.30",
				"DIOPT Score": "1",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/2906299",
				"Gene2 Symbol": "CD300H",
				"1-Protein Acc": "NP_000668",
				"2-Protein Acc": "NP_001311002",
				"Alignment Length": "77",
				"Identity Score": "0.29",
				"Similarity Score": "0.45",
				"Common GO slim": "",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0",
				"Coexpressed Samples": "0",
				"Tissue Expression Correlation": "0.00000",
				"Cell Line Expression Correlation": "0.00000"
			},
			{
				"Species": "human",
				"Species ID": "9606",
				"Gene1 Symbol": "ADORA3",
				"Paralog Score": "1.23",
				"DIOPT Score": "1",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/2906294",
				"Gene2 Symbol": "CD300LF",
				"1-Protein Acc": "NP_000668",
				"2-Protein Acc": "XP_016879701",
				"Alignment Length": "100",
				"Identity Score": "0.25",
				"Similarity Score": "0.39",
				"Common GO slim": "GO:0005623(cell);GO:0007165(signal transduction)",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0",
				"Coexpressed Samples": "0",
				"Tissue Expression Correlation": "0.08985",
				"Cell Line Expression Correlation": "0.50067"
			},
			{
				"Species": "human",
				"Species ID": "9606",
				"Gene1 Symbol": "ADORA3",
				"Paralog Score": "1.21",
				"DIOPT Score": "1",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/2906300",
				"Gene2 Symbol": "CD300LD",
				"1-Protein Acc": "NP_000668",
				"2-Protein Acc": "NP_001108624",
				"Alignment Length": "24",
				"Identity Score": "0.42",
				"Similarity Score": "0.62",
				"Common GO slim": "GO:0005623(cell)",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0",
				"Coexpressed Samples": "0",
				"Tissue Expression Correlation": "-0.01759",
				"Cell Line Expression Correlation": "0.04177"
			},
			{
				"Species": "human",
				"Species ID": "9606",
				"Gene1 Symbol": "ADORA3",
				"Paralog Score": "1.12",
				"DIOPT Score": "1",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/2906295",
				"Gene2 Symbol": "CD300LG",
				"1-Protein Acc": "NP_000668",
				"2-Protein Acc": "XP_006721784",
				"Alignment Length": "47",
				"Identity Score": "0.30",
				"Similarity Score": "0.57",
				"Common GO slim": "GO:0005623(cell)",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0",
				"Coexpressed Samples": "1",
				"Tissue Expression Correlation": "0.03582",
				"Cell Line Expression Correlation": "0.10099"
			},
			{
				"Species": "human",
				"Species ID": "9606",
				"Gene1 Symbol": "ADORA3",
				"Paralog Score": "1.09",
				"DIOPT Score": "1",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/2906297",
				"Gene2 Symbol": "TREML1",
				"1-Protein Acc": "NP_000668",
				"2-Protein Acc": "XP_016866311",
				"Alignment Length": "57",
				"Identity Score": "0.32",
				"Similarity Score": "0.46",
				"Common GO slim": "GO:0005623(cell)",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0",
				"Coexpressed Samples": "0",
				"Tissue Expression Correlation": "0.09517",
				"Cell Line Expression Correlation": "0.13923"
			},
			{
				"Species": "human",
				"Species ID": "9606",
				"Gene1 Symbol": "ADORA3",
				"Paralog Score": "1.06",
				"DIOPT Score": "1",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/2906287",
				"Gene2 Symbol": "PIGR",
				"1-Protein Acc": "NP_000668",
				"2-Protein Acc": "NP_002635",
				"Alignment Length": "90",
				"Identity Score": "0.27",
				"Similarity Score": "0.41",
				"Common GO slim": "GO:0004871(signal transducer activity);GO:0005623(cell);GO:0007165(signal transduction)",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0",
				"Coexpressed Samples": "1",
				"Tissue Expression Correlation": "0.03952",
				"Cell Line Expression Correlation": "0.00328"
			},
			{
				"Species": "human",
				"Species ID": "9606",
				"Gene1 Symbol": "ADORA3",
				"Paralog Score": "1.05",
				"DIOPT Score": "1",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/2906289",
				"Gene2 Symbol": "CD300C",
				"1-Protein Acc": "NP_000668",
				"2-Protein Acc": "XP_016879522",
				"Alignment Length": "66",
				"Identity Score": "0.23",
				"Similarity Score": "0.39",
				"Common GO slim": "GO:0004871(signal transducer activity);GO:0005623(cell)",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "",
				"Common Protein Interactors": "1",
				"Common Genetic Interactors": "0",
				"Coexpressed Samples": "0",
				"Tissue Expression Correlation": "0.15210",
				"Cell Line Expression Correlation": "0.44463"
			},
			{
				"Species": "human",
				"Species ID": "9606",
				"Gene1 Symbol": "ADORA3",
				"Paralog Score": "1.04",
				"DIOPT Score": "1",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/2906290",
				"Gene2 Symbol": "CD300A",
				"1-Protein Acc": "NP_000668",
				"2-Protein Acc": "NP_009192",
				"Alignment Length": "63",
				"Identity Score": "0.21",
				"Similarity Score": "0.46",
				"Common GO slim": "GO:0004871(signal transducer activity);GO:0005623(cell);GO:0007165(signal transduction)",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0",
				"Coexpressed Samples": "4",
				"Tissue Expression Correlation": "-0.00904",
				"Cell Line Expression Correlation": "0.34754"
			},
			{
				"Species": "human",
				"Species ID": "9606",
				"Gene1 Symbol": "ADORA3",
				"Paralog Score": "1.00",
				"DIOPT Score": "1",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/2906288",
				"Gene2 Symbol": "FCMR",
				"1-Protein Acc": "NP_000668",
				"2-Protein Acc": "NP_005440",
				"Alignment Length": "31",
				"Identity Score": "0.29",
				"Similarity Score": "0.55",
				"Common GO slim": "",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0",
				"Coexpressed Samples": "1",
				"Tissue Expression Correlation": "-0.02826",
				"Cell Line Expression Correlation": "0.03825"
			},
			{
				"Species": "human",
				"Species ID": "9606",
				"Gene1 Symbol": "ADORA3",
				"Paralog Score": "0.99",
				"DIOPT Score": "1",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/2906298",
				"Gene2 Symbol": "CD300E",
				"1-Protein Acc": "NP_000668",
				"2-Protein Acc": "XP_016880064",
				"Alignment Length": "76",
				"Identity Score": "0.18",
				"Similarity Score": "0.34",
				"Common GO slim": "GO:0005623(cell)",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0",
				"Coexpressed Samples": "0",
				"Tissue Expression Correlation": "0.02194",
				"Cell Line Expression Correlation": "0.00366"
			},
			{
				"Species": "human",
				"Species ID": "9606",
				"Gene1 Symbol": "ADORA3",
				"Paralog Score": "0.98",
				"DIOPT Score": "1",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/2906293",
				"Gene2 Symbol": "CD300LB",
				"1-Protein Acc": "NP_000668",
				"2-Protein Acc": "XP_005257084",
				"Alignment Length": "22",
				"Identity Score": "0.27",
				"Similarity Score": "0.55",
				"Common GO slim": "GO:0005623(cell)",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0",
				"Coexpressed Samples": "0",
				"Tissue Expression Correlation": "0.00809",
				"Cell Line Expression Correlation": "0.52850"
			},
			{
				"Species": "human",
				"Species ID": "9606",
				"Gene1 Symbol": "ADORA3",
				"Paralog Score": "0.93",
				"DIOPT Score": "1",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/2906292",
				"Gene2 Symbol": "FCAMR",
				"1-Protein Acc": "NP_000668",
				"2-Protein Acc": "NP_001164102",
				"Alignment Length": "52",
				"Identity Score": "0.31",
				"Similarity Score": "0.37",
				"Common GO slim": "GO:0005623(cell)",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0",
				"Coexpressed Samples": "0",
				"Tissue Expression Correlation": "-0.18655",
				"Cell Line Expression Correlation": "0.10941"
			},
			{
				"Species": "human",
				"Species ID": "9606",
				"Gene1 Symbol": "ADORA3",
				"Paralog Score": "0.83",
				"DIOPT Score": "1",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/2906291",
				"Gene2 Symbol": "TREM2",
				"1-Protein Acc": "NP_000668",
				"2-Protein Acc": "NP_061838",
				"Alignment Length": "43",
				"Identity Score": "0.23",
				"Similarity Score": "0.30",
				"Common GO slim": "GO:0005623(cell);GO:0007165(signal transduction)",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0",
				"Coexpressed Samples": "4",
				"Tissue Expression Correlation": "0.79346",
				"Cell Line Expression Correlation": "0.15894"
			}
		],
		"mouse": [
			{
				"Species": "mouse",
				"Species ID": "10090",
				"Gene1 Symbol": "Adora3",
				"Paralog Score": "3.22",
				"DIOPT Score": "3",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/3340597",
				"Gene2 Symbol": "Adora1",
				"1-Protein Acc": "NP_033761",
				"2-Protein Acc": "NP_001008533",
				"Alignment Length": "310",
				"Identity Score": "0.47",
				"Similarity Score": "0.69",
				"Common GO slim": "GO:0002376(immune system process);GO:0004871(signal transducer activity);GO:0006810(transport);GO:0006950(response to stress);GO:0040011(locomotion);GO:0005623(cell);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0007267(cell-cell signaling);GO:0048870(cell motility)",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "AdoR(DIOPT=5,7);",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0"
			},
			{
				"Species": "mouse",
				"Species ID": "10090",
				"Gene1 Symbol": "Adora3",
				"Paralog Score": "3.10",
				"DIOPT Score": "4",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/3340599",
				"Gene2 Symbol": "Adora2b",
				"1-Protein Acc": "NP_033761",
				"2-Protein Acc": "NP_031439",
				"Alignment Length": "304",
				"Identity Score": "0.40",
				"Similarity Score": "0.60",
				"Common GO slim": "GO:0004871(signal transducer activity);GO:0006810(transport);GO:0006950(response to stress);GO:0005623(cell);GO:0007165(signal transduction);GO:0016192(vesicle-mediated transport);GO:0002376(immune system process)",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "mAChR-C(DIOPT=1,1);AdoR(DIOPT=5,8);",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0"
			},
			{
				"Species": "mouse",
				"Species ID": "10090",
				"Gene1 Symbol": "Adora3",
				"Paralog Score": "2.95",
				"DIOPT Score": "4",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/3340598",
				"Gene2 Symbol": "Adora2a",
				"1-Protein Acc": "NP_033761",
				"2-Protein Acc": "NP_001318024",
				"Alignment Length": "297",
				"Identity Score": "0.43",
				"Similarity Score": "0.64",
				"Common GO slim": "GO:0004871(signal transducer activity);GO:0006810(transport);GO:0006950(response to stress);GO:0040011(locomotion);GO:0005623(cell);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0007267(cell-cell signaling);GO:0002376(immune system process)",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "AdoR(DIOPT=5,9);mAChR-C(DIOPT=1,1);",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0"
			},
			{
				"Species": "mouse",
				"Species ID": "10090",
				"Gene1 Symbol": "Adora3",
				"Paralog Score": "2.32",
				"DIOPT Score": "1",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/3340611",
				"Gene2 Symbol": "Gpbar1",
				"1-Protein Acc": "NP_033761",
				"2-Protein Acc": "NP_778150",
				"Alignment Length": "316",
				"Identity Score": "0.22",
				"Similarity Score": "0.38",
				"Common GO slim": "GO:0004871(signal transducer activity);GO:0005623(cell);GO:0007165(signal transduction)",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "AdoR(DIOPT=5,1);",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0"
			},
			{
				"Species": "mouse",
				"Species ID": "10090",
				"Gene1 Symbol": "Adora3",
				"Paralog Score": "1.84",
				"DIOPT Score": "1",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/3340613",
				"Gene2 Symbol": "Cd300ld3",
				"1-Protein Acc": "NP_033761",
				"2-Protein Acc": "NP_954671",
				"Alignment Length": "203",
				"Identity Score": "0.21",
				"Similarity Score": "0.33",
				"Common GO slim": "GO:0006950(response to stress);GO:0005623(cell);GO:0002376(immune system process);GO:0007165(signal transduction)",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0"
			},
			{
				"Species": "mouse",
				"Species ID": "10090",
				"Gene1 Symbol": "Adora3",
				"Paralog Score": "1.84",
				"DIOPT Score": "1",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/3340616",
				"Gene2 Symbol": "Cd300ld5",
				"1-Protein Acc": "NP_033761",
				"2-Protein Acc": "NP_001095127",
				"Alignment Length": "203",
				"Identity Score": "0.21",
				"Similarity Score": "0.33",
				"Common GO slim": "",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0"
			},
			{
				"Species": "mouse",
				"Species ID": "10090",
				"Gene1 Symbol": "Adora3",
				"Paralog Score": "1.58",
				"DIOPT Score": "1",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/3340606",
				"Gene2 Symbol": "Cd300c2",
				"1-Protein Acc": "NP_033761",
				"2-Protein Acc": "NP_598919",
				"Alignment Length": "146",
				"Identity Score": "0.21",
				"Similarity Score": "0.38",
				"Common GO slim": "GO:0005623(cell);GO:0006810(transport)",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0"
			},
			{
				"Species": "mouse",
				"Species ID": "10090",
				"Gene1 Symbol": "Adora3",
				"Paralog Score": "1.54",
				"DIOPT Score": "1",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/3340609",
				"Gene2 Symbol": "Cd300ld",
				"1-Protein Acc": "NP_033761",
				"2-Protein Acc": "NP_663412",
				"Alignment Length": "145",
				"Identity Score": "0.20",
				"Similarity Score": "0.33",
				"Common GO slim": "GO:0005623(cell)",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0"
			},
			{
				"Species": "mouse",
				"Species ID": "10090",
				"Gene1 Symbol": "Adora3",
				"Paralog Score": "1.54",
				"DIOPT Score": "1",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/3340615",
				"Gene2 Symbol": "Cd300ld4",
				"1-Protein Acc": "NP_033761",
				"2-Protein Acc": "XP_017169686",
				"Alignment Length": "134",
				"Identity Score": "0.25",
				"Similarity Score": "0.39",
				"Common GO slim": "",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0"
			},
			{
				"Species": "mouse",
				"Species ID": "10090",
				"Gene1 Symbol": "Adora3",
				"Paralog Score": "1.21",
				"DIOPT Score": "1",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/3340614",
				"Gene2 Symbol": "Cd300c",
				"1-Protein Acc": "NP_033761",
				"2-Protein Acc": "NP_001355168",
				"Alignment Length": "74",
				"Identity Score": "0.22",
				"Similarity Score": "0.43",
				"Common GO slim": "GO:0005623(cell)",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0"
			},
			{
				"Species": "mouse",
				"Species ID": "10090",
				"Gene1 Symbol": "Adora3",
				"Paralog Score": "1.19",
				"DIOPT Score": "1",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/3340610",
				"Gene2 Symbol": "Cd300e",
				"1-Protein Acc": "NP_033761",
				"2-Protein Acc": "NP_742047",
				"Alignment Length": "26",
				"Identity Score": "0.42",
				"Similarity Score": "0.58",
				"Common GO slim": "GO:0005623(cell)",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0"
			},
			{
				"Species": "mouse",
				"Species ID": "10090",
				"Gene1 Symbol": "Adora3",
				"Paralog Score": "1.18",
				"DIOPT Score": "1",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/3340607",
				"Gene2 Symbol": "Cd300a",
				"1-Protein Acc": "NP_033761",
				"2-Protein Acc": "NP_001346741",
				"Alignment Length": "118",
				"Identity Score": "0.22",
				"Similarity Score": "0.36",
				"Common GO slim": "GO:0002376(immune system process);GO:0004871(signal transducer activity);GO:0006810(transport);GO:0006950(response to stress);GO:0040011(locomotion);GO:0005623(cell);GO:0007165(signal transduction);GO:0016192(vesicle-mediated transport);GO:0048870(cell motility)",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0"
			},
			{
				"Species": "mouse",
				"Species ID": "10090",
				"Gene1 Symbol": "Adora3",
				"Paralog Score": "1.13",
				"DIOPT Score": "1",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/3340602",
				"Gene2 Symbol": "Fcamr",
				"1-Protein Acc": "NP_033761",
				"2-Protein Acc": "NP_001164103",
				"Alignment Length": "71",
				"Identity Score": "0.30",
				"Similarity Score": "0.49",
				"Common GO slim": "GO:0004871(signal transducer activity);GO:0005623(cell);GO:0002376(immune system process)",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0"
			},
			{
				"Species": "mouse",
				"Species ID": "10090",
				"Gene1 Symbol": "Adora3",
				"Paralog Score": "1.13",
				"DIOPT Score": "1",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/3340605",
				"Gene2 Symbol": "Trem2",
				"1-Protein Acc": "NP_033761",
				"2-Protein Acc": "NP_001259007",
				"Alignment Length": "94",
				"Identity Score": "0.19",
				"Similarity Score": "0.34",
				"Common GO slim": "GO:0004871(signal transducer activity);GO:0006810(transport);GO:0006950(response to stress);GO:0005623(cell);GO:0007165(signal transduction);GO:0016192(vesicle-mediated transport);GO:0002376(immune system process)",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0"
			},
			{
				"Species": "mouse",
				"Species ID": "10090",
				"Gene1 Symbol": "Adora3",
				"Paralog Score": "1.08",
				"DIOPT Score": "1",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/3340608",
				"Gene2 Symbol": "Cd300lb",
				"1-Protein Acc": "NP_033761",
				"2-Protein Acc": "NP_954691",
				"Alignment Length": "55",
				"Identity Score": "0.22",
				"Similarity Score": "0.42",
				"Common GO slim": "GO:0005623(cell);GO:0002376(immune system process)",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0"
			},
			{
				"Species": "mouse",
				"Species ID": "10090",
				"Gene1 Symbol": "Adora3",
				"Paralog Score": "1.06",
				"DIOPT Score": "1",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/3340612",
				"Gene2 Symbol": "Cd300lf",
				"1-Protein Acc": "NP_033761",
				"2-Protein Acc": "NP_001162624",
				"Alignment Length": "65",
				"Identity Score": "0.29",
				"Similarity Score": "0.38",
				"Common GO slim": "GO:0005623(cell);GO:0002376(immune system process);GO:0007165(signal transduction)",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0"
			},
			{
				"Species": "mouse",
				"Species ID": "10090",
				"Gene1 Symbol": "Adora3",
				"Paralog Score": "1.03",
				"DIOPT Score": "1",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/3340603",
				"Gene2 Symbol": "Fcmr",
				"1-Protein Acc": "NP_033761",
				"2-Protein Acc": "NP_081252",
				"Alignment Length": "58",
				"Identity Score": "0.29",
				"Similarity Score": "0.43",
				"Common GO slim": "GO:0005623(cell);GO:0005886(plasma membrane);GO:0007165(signal transduction)",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0"
			},
			{
				"Species": "mouse",
				"Species ID": "10090",
				"Gene1 Symbol": "Adora3",
				"Paralog Score": "1.00",
				"DIOPT Score": "1",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/3340601",
				"Gene2 Symbol": "Cd300lg",
				"1-Protein Acc": "NP_033761",
				"2-Protein Acc": "NP_001154183",
				"Alignment Length": "35",
				"Identity Score": "0.34",
				"Similarity Score": "0.49",
				"Common GO slim": "GO:0016192(vesicle-mediated transport);GO:0005623(cell);GO:0006810(transport);GO:0005886(plasma membrane)",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0"
			},
			{
				"Species": "mouse",
				"Species ID": "10090",
				"Gene1 Symbol": "Adora3",
				"Paralog Score": "0.97",
				"DIOPT Score": "1",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/3340600",
				"Gene2 Symbol": "Pigr",
				"1-Protein Acc": "NP_033761",
				"2-Protein Acc": "NP_035212",
				"Alignment Length": "43",
				"Identity Score": "0.23",
				"Similarity Score": "0.56",
				"Common GO slim": "GO:0004871(signal transducer activity);GO:0006810(transport);GO:0005623(cell);GO:0007165(signal transduction);GO:0016192(vesicle-mediated transport);GO:0002376(immune system process)",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0"
			},
			{
				"Species": "mouse",
				"Species ID": "10090",
				"Gene1 Symbol": "Adora3",
				"Paralog Score": "0.96",
				"DIOPT Score": "1",
				"Paralog Pair URL": "https://www.flyrnai.org/tools/paralogs/web/expression/3340604",
				"Gene2 Symbol": "Treml1",
				"1-Protein Acc": "NP_033761",
				"2-Protein Acc": "NP_082039",
				"Alignment Length": "28",
				"Identity Score": "0.29",
				"Similarity Score": "0.50",
				"Common GO slim": "GO:0006950(response to stress);GO:0005623(cell);GO:0007165(signal transduction)",
				"Common Yeast Paralogs": "",
				"Common Fly Paralogs": "",
				"Common Protein Interactors": "0",
				"Common Genetic Interactors": "0"
			}
		],
		"worm": [],
		"zebrafish": []
	}
}
